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ABSTRACT 
Pannexins (Panxs) are a recently identified family of channel-forming glycoproteins, 
comprised of three members: Panx1, Panx2 and Panx3. Panxs were classified as 
gap junction (GJ) proteins based on their shared sequence homology to the 
invertebrate GJ protein, innexins. While no sequence homology exist between 
Panxs and the GJ proteins, connexins (Cxs), they share similar topology with four 
transmembrane domains, two extracellular loops, an intracellular loop and 
cytoplasmic exposed amino and carboxy terminal tails. In this study, we investigated 
if Panx1 and Panx3 exhibit unique or shared properties of cell surface delivery, 
mobility, cytoskeletal dependency, internalization and degradation, to the well 
characterized Cx43 GJ protein. Over-expression of a dominant-negative Sar1 
mutant revealed that, like Cx43, Panx1 and Panx3 followed the classical secretory 
pathway en route to the cell surface. At the plasma membrane, Panx1 and Panx3 
distributed in a relatively uniform pattern independent of the presence of an adjoining 
cell, a feature distinct from the punctate localization of Cx43 at cell-cell apposition. 
Rapid time-lapse imaging and photo-bleaching revealed high mobility of Panx1 and 
Panx3 at the cell surface, unlike Cx43-GJs. Using pharmacological inhibitors of 
microtubule and microfilament polymerization, Panx1 and Panx3 were identified to 
rely primarily on actin filaments for their overall cell surface stability. Interestingly, co-
sedimentation and co-immunoprecipitation assays revealed that actin bound directly 
to the C-terminal tail of Panx1. Truncation of the Panx1 C-terminal tail at residue 307 
(Panx1T307) inhibited its trafficking to the cell surface causing it to be retained within 
the endoplasmic reticulum. Co-expression of full length Panx1 could not rescue the 
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delivery of Panx1T307 to the cell surface but exhibited limited co-interaction. Blocking 
of protein synthesis and secretion revealed a prolonged half-life of Panx1 in 
comparison to Cx43. Rapid time-lapse imaging of cells expressing Panx1-GFP 
uncovered a unique pattern of Panx1 internalization through dynamic tubular-like 
extensions.  Chloroquine-induced inhibition of lysosomal function revealed that 
Panx1 is degraded by lysosomes. Collectively, our studies show that Panx1 and 
Panx3 exhibit many properties that are distinct from Cx43, further supporting that 
pannexins forms a unique class of channel proteins that should be considered 
separate from connexin-based GJ channels.   
Keywords 
Pannexins, connexin43, rapid time-lapse imaging, fluorescence recovery after 
photo-bleaching and cytoskeletal elements 
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1  INTRODUCTION 
1.1 Evolutionary aspect of innexins, connexins and 
pannexins 
A family of channel forming proteins, termed pannexins (Panxs), was first 
identified in the year 2000 by Panchin and colleagues [1]. Pannexins were 
discovered as the vertebrate homologs of invertebrate gap junction proteins, 
innexins (Inxs) [1, 2], and were therefore proposed to share functional features 
similar to gap junctions.  
Gap junctions (GJs) are tightly packed intercellular channels that are assembled 
from two halves or hemi-channels composed of GJ proteins [3, 4]. GJ channels 
connect the cytoplasm of two apposing cells for bi-directional passage of ions, 
small metabolites and messenger molecules less than 1 kDa in size [4, 5]. The 
intercellular communication mediated by GJ channels regulates physiological 
processes related to development, synchronization, differentiation and 
proliferation [6-8].  
In the 1980s, the pioneer work done on characterizing GJs led to the 
identification of a multigene family of vertebrate proteins, connexins (Cxs) [9, 10], 
and the nomenclature of Cxs was based according to their predicted molecular 
mass [9, 10]. Ever since the cloning of the first connexin, Cx32, from rat and 
human liver [11, 12], 20 murine and 21 human connexin family members have 
been identified [13]. Based on the cDNA and genomic sequences, Cxs were also 
evident in animals of chordate branch: tunicates, ascidians and appendicularians 
(GenBank accession numbers AY380580, AY386312, AY386311) [14]. Despite 
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being a large family, several initiatives could not identify connexin homologs in 
the genomes of Caenorhabditis elegans (nematode) or Drosophila melanogaster 
(arthropod), thereby suggesting an existence of a distinct family of proteins for 
the formation of GJs in invertebrates [15].  A second GJ protein, unrelated to 
Cxs, was then found in several bilaterian protostome phylas including 
Platyhelminthes, Nematoda, Annelida, Molluscs and Arthropoda (Figure 1.1). 
This family of proteins was originally designated as OPUS, derived from the 
founding members: ogre, Passover, unc-7 and shaking-B, but were later 
renamed innexins (invertebrate analog of connexin) based on their shared ability 
to form intercellular channels, like connexins [16-20].   
With the renaming of invertebrate GJs to innexins, the genomic sequence of 
mollusk and flatworm were aligned and compared against the human genome 
using a PSI-BLAST (Position Specific Iterative-Basic Local Alignment Search 
Tool) approach [21]. The BLAST search identified two mRNA sequences with no 
previously assigned functions that encoded MRS1 (GenBank accession number 
AF093239) and MRS1-related proteins (GenBank accession number AL022328). 
Interestingly, sequence searches based on the MRS1 protein retrieved the 
invertebrate gap junction protein, Unc-7 from C. elegans, thus expanding the 
innexin homolog family into the chordata phyla [21].  Due to the apparent 
ubiquitous presence of this family of proteins in the metazoan animal kingdom, 
and their putative role as GJs, they were termed ‘pannexins’ (from the Latin Pan-
all, throughout and nexus- connection) [1, 21]. As a result, the human MRS1 
protein was denoted as PANX1, and its related form as PANX2. In addition, a 
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protein sequence query (TBLASTN) applied against the human genome detected 
a final member of this family, PANX3 [21].  
From an evolutionary perspective, it appeared that innexins emerged to provide 
gap junctional intercellular communication in animals of Cnidarian lineage, which 
was later inherited by protostomes and deuterostomes (Figure 1.1). In 
comparison, Cxs emerged in deuterostomes as a second class of GJ proteins, 
presumably by a gene duplication in the early protochordate lineage [22].  This 
divergence led innexins to be found in a subfamily within deuterostomes- as 
pannexins [23].  
Connexins were originally identified to be chordate-specific, however, additional 
genomic sequence analysis from other organisms have shown some exception 
to this criteria, as animals (e.g. lancelets) within one of the branches of the 
chordata phylum (cephalochordate) are devoid of connexins, but have pannexins 
[24] (Figure 1.1).  
From the functional point of view, pannexins might have emerged to provide 
compensatory, overlapping or unique physiological roles compared to that of 
connexins. The assessment of the phylogenetic relationship between different 
members of this superfamily has been an ongoing effort in the gap junction 
research community. Being a vertebrate homolog of innexins, it therefore 
became logical to determine if pannexins exhibited similar characteristics to the 
well studied gap junction proteins of vertebrates, connexins.    
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Figure 1.1 Evolutionary aspect of innexins, connexins and pannexins 
Schematic representation of presence (+) and absence (-) of innexins, 
connexins and pannexins in various taxonomic groups. Adapted from 
Shestopalov and Panchin (2008). 
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1.2 Human and murine pannexin genes 
Amino acid sequence alignment of the three human pannexins members: 
PANX1, PANX2 and PANX3, revealed 49-94% similarity with murine pannexins 
[2]. While human pannexins are written in uppercase, murine pannexins are 
represented by the Panx1, Panx2 and Panx3 nomenclature.  
PANX1 located on human chromosome 11q14.3, contains five exons and four 
introns and encodes a 426 amino acid protein (Accession number NP_056183) 
with an expected molecular mass of 47.6 kDa [21]. On the other hand, murine 
Panx1 is located on chromosome 9, and similar to human PANX1 encodes five 
exons and four introns [21], generating a product of 426 amino acids (Accession 
number NP_062355) with a molecular weight of ~45 kDa [25]. 
PANX2 located on human chromosome 22q13.31-13.33, contains 4 exons and 
has two protein isoforms [21]. PANX2 isoform 1 contains 677 amino acids 
(Accession number NP_443071), and isoform 2 contains 643 amino acids 
(Accession number NP_001153772), with a predicted molecular mass of ~70 
kDa [21]. The murine Panx2 is located on chromosome 15 and similar to the 
human PANX2, contains 4 exons and encodes a protein product of 677 amino 
acids (Accession number NP_001002005) with a molecular weight of ~80 kDa 
[21]. Finally, the human PANX3 is similar to the murine Panx3, as they both 
contain 4 exons and encodes a 392 amino acids long protein with a molecular 
weight of ~44.7 kDa and ~43 kDa, respectively (human: Accession number 
NP_443191; murine: Accession number NP_766042) [21]. While human PANX3 
is located on 11q24.2, murine Panx3 is located on chromosome 9 [21].   
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Interestingly, both the human and murine pannexin genes for Panx2 and Panx3 
are located on shorter chromosome segments (less than 6 kb from first to last 
exon) than Panx1 (more than 40 kb from first to last exon) [21]. Moreover, Panx1 
and Panx3 are located on the same chromosomes in human and mouse, with a 
separation of 30 Mb and 22 Mb, respectively, and share 41% identity and 59% 
conservation at the primary structure level [21]. Given the overall similarity in the 
exon-intron organization, chromosomal location, and the shared conservation at 
the amino acid level, it is postulated that the close relationship of Panx1 and 
Panx3 may have arisen from chromosomal duplication [21]. Furthermore, the 
phylogenetic mapping of vertebrate pannexins revealed more divergence of 
Panx1 from Panx2, suggesting unique roles for these family members [21]. Given 
that Panx1 and Panx3 are more closely related to each other, this thesis will 
predominantly focus on these two members of the pannexin family.  
1.3 Diversity of pannexin expression  
In addition to the human and mouse genomes, the expression of all three 
pannexin members have now been identified in at least 5 more species including: 
Rattus norvegicus (rat), Canis familaris (dog), Bos Taurus (cow), Danio rerio 
(zebrafish) and Tetraodon nogrovirdis (puffer fish) [2]. Despite the vast inter-
species distribution, pannexins are most well characterized in human and rodent 
tissues, with Panx1 being the most studied member. The first studies relied on 
detecting pannexins at only the transcript level due to the unavailability of high-
quality, custom-designed antibodies. 
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1.3.1 Pannexin1 
Northern blot analysis of human tissues revealed Panx1 expression in brain, 
heart, skeletal muscle, skin, testis, ovary, placenta, thymus, prostate, lung, liver, 
small intestine, pancreas, spleen, colon, blood endothelium and erythrocytes 
[21]. In the central nervous system (CNS), Panx1 transcripts were detected in 
cerebellum, cortex, lens (fiber cells), retina (retinal ganglion, amacrine and 
horizontal cells), pyramidal cells, interneurons of the neocortex and 
hippocampus, amygdale, substantia nigra, olfactory bulb, neurons and glial cells 
[21, 24, 26-35].  Developmentally, a gradient of Panx1 expression was found in 
mouse brain, such that higher levels were expressed during the embryonic 
(E13.5-18) and postnatal stages with lower levels in the adult brain [30, 32]. 
Notably, our tissue survey using custom-designed affinity purified anti-Panx1 
antibodies demonstrated a robust expression of Panx1 in the brain, with variable 
levels of Panx1  in the lung, kidney, spleen, heart ventricle, skin and sources of 
cartilage from ear and tail of a 3-week old mice [25]. More recently, Panx1 
protein expression was also detected in the rodent cochlea, specifically in 
supporting cells of the Organ of Corti, spiral limbus, cochlear lateral wall and 
strial blood vessels [36]. 
1.3.2 Pannexin2 
In comparison to Panx1, Panx2 mRNA was restricted to several areas of the 
human adult brain including:  cerebellum, cerebral cortex, medulla, occipital pole 
frontal lobe, temporal lobe and putamen [21]. While Northern blot analysis 
revealed higher levels of Panx2 transcript in the rodent brain, spinal cord and 
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eyes, other tissues such as thyroid, kidney and liver also revealed some level of 
Panx2 expression [26-28]. Interestingly, in-situ hybridization revealed co-
expression of Panx2 with Panx1 in various regions of adult rat brain, such as 
hippocampus, olfactory bulb, pyramidal cells, dentate gyrus, Purkinje cells of the 
cerebellum, pyramidal cells and interneurons of the hippocampus and neocortex 
[32]. Unlike Panx1, Panx2 transcript expression was low during prenatal 
development of rat brain, and substantially increased in postnatal brains [32].  
Recently, Panx2 protein expression was identified in the basal cells of the stria 
vascularis and spiral ganglion neurons of the rat cochlear system [36]. 
1.3.3 Pannexin3 
Based on expressed sequence tags, Panx3 was predicted to be present in 
osteoblasts, synovial fibroblasts, whole joints of mouse paws, and cartilage from 
the inner ear [21]. In addition, Panx3 transcript expression, albeit low, was also 
detected in human hippocampus extracts [21]. Recently, Panx3 protein 
expression was reported in murine cochlear bone [36], while in-situ hybridization 
of  embryonic day 16.5 mice strongly revealed Panx3 expression in 
prehypertrophic chondrocytes, perichondrium and osteoblasts [37]. Furthermore, 
we demonstrated that while Panx3 protein exhibits two forms at ~43 kDa and ~70 
kDa, when expressed in skin, cartilage, and ventricle, only the ~70 kDa species 
is detected in lung, liver, kidney, thymus and spleen of a 3 week old mice [25]. It 
is however yet to be determined if the occurrence of ~70 kDa species is due to a 
splice variant or Panx3 dimerization.   
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1.4 Pannexin family members share similar topology to   
    connexins 
The discovery of pannexins led to further analysis of the protein topology using 
multiple sequence alignment systems [2].  Connexins, innexins and pannexins all 
share the same topology with four alpha-helical transmembrane (TM) domains, 
two extracellular loops (EL), one intracellular loop (IL) and intracellular amino 
(NT) and carboxy (CT) termini [1, 2, 21] (Figure 1.2).  While primary sequence 
homology does not exist between Panxs and Cxs, various motifs of Panxs and 
Inxs share significant sequence homology [2]. Both Inxs and Panxs share two 
cysteine residues in each of their EL domains (Figure 1.2), with the exception of 
Drosophila Inx4 that has 3 pairs of cysteines [2, 38].   
The two cysteine residues within the 1st EL are fully conserved between Panxs 
and Inxs, with 37% identity and 58% amino acid similarity when flanked by 24 
additional amino acids. However, only 1 of the 2 cysteine residues is conserved 
in the 2nd EL of Panxs and Inxs [2]. Comparatively, the well characterized Cx 
family member, Cx43, has 3 cysteine residues in each of its ELs [39] (Figure 1.2) 
which is the same for all characterized connexins with the exception of Cx23, 
which harbors 2 pairs of cysteines [40]. In the case of Cx43, and likely all other 
family members, these cysteine residues are critical for forming intramolecular 
disulfide linkages between ELs, such that when docked at the apposing plasma 
membrane, each half of the GJ channel is stabilized by intermolecular hydrogen 
bonds [41]. 
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Figure 1.2 Topology of innexins, connexins and pannexins 
Panx1, Panx2 and Panx3 share similar topology of four transmembrane domains 
(TM), two extracellular loops (EL), one intracellular loop (IL) and intracellular 
amino (NT) and carboxy (CT) groups with innexins and Cx43. Pannexins and 
innexins also share two cysteine residues in each of their ELs, while Cx43 has 
three cysteine residues. Panx1 is glycosylated on the second EL, whereas Panx2 
and Panx3 are glycosylated on the first EL. 
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Interestingly, a signature sequence of all Inxs (YYQWV) is not conserved in 
Panxs. However, this motif along with a 23 amino acid flanking region in Inxs 
exhibits 39% identity and 61% similarity in TM2 of Panxs [2]. Additionaly, a 
proline motif (correlated with conformation changes associated with channel-
gating in Cxs) is conserved in TM2 of Inxs and Panxs, and is found in relatively 
the same position in Cxs [42].  
While Inxs and Panxs contain two fully conserved cysteine residues in their CT 
region, it is the NT domains that are better conserved [2].  All connexin members 
posses almost the same length of intracellular NT domain with major differences 
found in the length of the CT domain [43]. In contrast to Panx1 and Panx3, 
Panx2 exhibits a very large CT domain (Figure 1.2) which is speculated to 
convey unique functions to Panx2 regulation, targeting or macromolecular 
interactions [2]. The regulatory role of the Cx43 CT domain is multifaceted. This 
includes many interactions with scaffolding and cytoskeletal proteins [44] that 
contribute to the overall size and number of gap junction plaques at the cell 
surface [45] and the channel gating properties [46]. However, the role of the CT 
domain in Panxs has yet to be investigated. 
1.5 Pannexins and connexins form multimeric channels 
Initial characterization of Panx1 oligomerization revealed that 6 subunits were 
required for a channel formation [47]. The monomers of Panx1 resolved at ~43-
49 kDa, whereas the dimeric and hexameric configuration was detected at ~98 
kDa and ~290 kDa, respectively [47]. While Panx1 and Cx43 channels share a 
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hexameric configuration, this is quite different from the heptamers or octomers 
reported for Panx2 [48].  On the other hand, the state of oligomerization for 
Panx3 is currently unknown.  Distinct from Cx43, Panx1 forms a wider pore 
channel [49] likely due to relatively longer ELs (~50-60 amino acids) than seen in 
Cxs (~30 amino acids) [24] (Figure 1.2). Pannexin hexamers are termed 
pannexons [47], following the nomenclature devised for connexins (as connexin 
hexamers are termed connexons) [3, 4].  While ‘connexons’ are also referred as 
‘hemi-channels’ (i.e. a structure constituting half of the channel), the term 
‘pannexons’ primarily reflects the single-membrane channel. It is well established 
that connexons from adjacent cells dock at the plasma membrane to form 
intercellular channels, however, an ongoing effort continues in the field to deduce 
if single membrane channels of pannexins also possess the capability to form 
intercellular junctions [50].  
1.6 Pannexins do not readily form intercellular channels 
Currently, there are conflicting reports in the literature as to whether pannexins 
are involved in direct intercellular communication. It was initially reported that 
over-expression of Panx1 mRNA, but not Panx2 or Panx3, formed intercellular 
channels, albeit, 24-48 hours after pairing Xenopus oocytes [26, 51, 52]. In a 
parallel study, Boassa et al., [47] reported that while Panx1 intercellular 
channels did not form resulting in a significant junctional conductance within 6 
hours of oocytes pairing, the Cx46 formed robust intercellular channels within 1 
hour [47].  Additional evidence of intercellular channel formation by Panx1 was 
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derived from two independent studies using C6 glioma cells [53] and LNCaP 
prostate cancer epithelial cells [54]. While these studies revealed the passing of 
sulfurodamine 101 dye in C6 gliomas [53] and Ca2+ permeability in LNCaP 
neighboring cells [54], they were performed under highly artificial conditions of 
either bathing or perfusing the cells with chemical agents, thus questioning the 
ability of pannexins to readily or efficiently form intercellular channels. A scrape 
loading assay (a commonly used technique to detect intercellular 
communication) conducted by Boassa et al., [47] further revealed the inability of 
Panx1 to pass Lucifer yellow dye in communication-deficient Madin-Darby 
Canine Kidney cells. This study was in line with our findings that revealed no 
electrical coupling conductance in gap junction-deficient neuro-2A (N2A) cells 
expressing either Panx1 or Panx3 [25]. Additional reports in erythrocytes [55] as 
well as neuronal and glial cells [56] have also failed to provide evidence that 
Panxs can in fact form gap junctions, thus providing further indication that the 
pannexin family of proteins does not serve a role redundant to that of connexins 
by readily forming intercellular channels.  
1.7 Pannexins form functional non-junctional channels  
It was first identified in 2003, that Panx1, but not Panx2, possesses the ability to 
form non-junctional membrane channels, in single Xenopus oocytes [26]. The 
unitary conductance of Panx1 single-membrane channels was determined to be 
550 pS [57], which was approximately 200 pS larger than that of any of the 
connexins [58]. Co-injections of Panx1 and Panx2 transcripts, revealed a ~15% 
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reduction in the conductance of heterotypic channels (comprised of different 
subunits), thus reflecting a dominant negative effect of Panx2 on Panx1 channel 
function [26]. Since then, we have reported that all family members: Panx1, 
Panx2 and Panx3 can form variable levels of single-membrane channels, 
capable of dye uptake [59]. However, intermixing of Panx1 with Panx2, but not 
Panx3, attenuated the channel function by lowering the incidence of dye uptake 
[59]. While Panx1 channels can be activated by mechanical stimulation, 
cytoplasmic Ca2+, membrane depolarization and extracellular ATP [49, 57, 60-
62]; its conductance is abolished by CO2-mediated cytoplasmic acidification [60], 
negative feedback from ATP release [63], mimetic peptides [64] and channel 
blockers such as carbenoxolone, probenecid  and fluefenamic acid [65, Barbe, 
2006 #3]. It is now well established that the activation of pannexin single-
membrane channels allows for cellular communication with the extracellular 
environment to fulfill a diverse range of functions [50, 56, 60, 66, 67]. 
1.8 Physiological roles of pannexin single-membrane 
channels 
1.8.1 Paracrine signaling mediated by Panx1 
Indirect communication between cells is typically mediated through activation of 
single-membrane channels and releasing molecules such as ATP [68] into the 
extracellular space.  
Calcium waves: Ca2+ is a versatile, ubiquitously expressed second messenger 
that can regulate several cellular responses [69]. Initiation of Ca2+ waves is 
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mediated by the activation of ATP-sensitive purinergic receptors, P2Y and P2X 
[70]. Binding of ATP to the membrane receptor increases inositol 1, 4, 5-
triphosphate, which in turn, releases Ca2+ from the ER stores. Once released, 
Ca2+ activates single-membrane channels, leading to further release of ATP, and 
propagation of signal to the neighboring cells [71]. Essential to this notion is the 
fact that Panx1 has been shown to be a part of the P2X7 receptor complex, 
necessary for ATP release [55, 72]. Furthermore, ATP-induced ATP release was 
also reported when Panx1 channels were activated through P2Y receptors and 
cytoplasmic Ca2+ [60], thus supporting the role of Panx1 in the initiation and 
propagation of regenerative Ca2+ signaling.  
Vasodilation:  Release of ATP from erythrocytes occurs during stress and 
hypoxic conditions [73].  It was recently discovered that erythrocytes 
endogenously express Panx1, and mechano-sensitive activation of Panx1 
channels regulate ATP release [55]. It is hypothesized that under conditions of 
stress, activation of Panx1 channels control blood flow, by releasing ATP from 
red blood cells, and initiating Ca2+ wave propagation through stimulation of 
purinergic receptors on the endothelial cells [55]. Elevation of Ca2+ subsequently 
releases NO onto the smooth muscle, leading to vasodilation [55]. 
Taste sensation: Taste buds are comprised of two distinct population of cells, 
some that express taste receptors (receptor cells), and others that contain 
synapses (presynaptic cells) [74]. It has been reported that Panx1 is expressed 
in the receptor cells, and upon taste stimulation, ATP is released through Panx1 
single-membrane channels [65, 74]. Once released in the extracellular medium, 
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ATP stimulates P2 receptors of the presynaptic cells to release serotonin (5-HT) 
[65, 74], thereby providing a mechanism for cell-cell signaling and information 
processing within taste bud.   
Airway defense: Airway epithelium provides a defense mechanism by controlling 
mucociliary clearance, which depends on maintaining adequate airway surface 
liquid volume and ciliary activity [75].  In the differentiated human airway 
epithelium cells, expression of Panx1 single-membrane channels in the apical 
region has been linked to ATP release under hypotonic stress [75].  Panx1-
evoked ATP release is proposed to be crucial for regulating the ciliary beat 
frequency and surface liquid volume for mucous clearance [75].  
1.8.2 Intracellular responses mediated by Panx1 
Immune response: Interaction of Panx1 with P2X7 receptors elicits an immune 
response by releasing the pro-inflammatory cytokine interleukin (IL)-1 β, in 
response to receptor stimulation by ATP followed by a subsequent activation of 
caspase-1 [49]. Panx1 is also reported to trigger the Toll-like receptor-
independent inflammasome (comprising cryopyrin), based on recognition of 
bacterial molecules passing from endosomes to cytosol [76]. Furthermore, P2X7-
mediated activation of Panx1 channel is potentiated by high extracellular K+ 
levels in neuronal/astrocytic inflammasomes [77].  
Tumorigenesis: Exogenous expression of Panx1 has been linked to tumor-
suppressive properties in C6 gliomas [53]. In the presence of Panx1, C6 gliomas 
exhibit a flattened morphology and a reduction in proliferation, motility, 
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anchorage-independent growth [53]. In addition, injection of Panx1 expressing 
cells in nude mice reduced the in vivo tumor growth [53].  Taken together, it is 
suggested that Panx1 plays a role as a tumor suppressor. 
Ischemic cell death and Epileptic seizure: The rapid decrease of O2 and glucose 
in mouse hippocampal pyramidal neurons has been associated with the opening 
of Panx1 single-membrane channels that leads to conductance of large currents 
[78]. This, in turn, causes a profound ionic dysregulation, thereby leading to 
neuronal death [78]. In addition, the N-methyl-D-aspartate receptor-based 
opening of Panx1 channels leads to epileptiform seizure activities in pyramidal 
neurons [66], further supporting the importance of precise regulation of Panx1 
channel openings. 
Apoptosis:  Panx1 forms the pore unit of the P2X7 death complex [72]. The co-
expression of Panx1 with P2X7 receptor revealed ATP-induced zeiosis in 
Xenopus oocytes, which was not observed upon the injection of Panx1 transcript 
alone or together with P2Y receptor [60, 72]. These results suggest that although 
activation of purinergic P2Y receptor can mediate Panx1 currents, the specific 
cell death signaling is through interaction with ionotropic P2X7 receptor. Quite 
recently, Panx1 channels have been documented to mediate the release of 
nucleotide signals from apoptotic cells for the recruitment of activated monocytes 
[79]. In this situation, Panx1 channels gets activated by caspases which cleave 
Panx1 and opens the channel for ATP and UTP release as a “find me” signal to 
attract phagocytes [79]. 
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Keratinocyte differentiation: We have previously shown that ectopically 
expressed Panx1 reduces the proliferation rate of rat epidermal keratinocytes 
(REKs), however, it does not significantly alter their migratory properties [67]. 
Furthermore, over-expression of Panx1 in organotypic cultures (generated from 
monolayer REKs) disrupts the overall architecture of the epidermis, reduces the 
thickness of vital layer (likely stratum spinosum and granulosum) and re-localizes 
the basal cell marker, cytokeratin 14, throughout the vital layer [67], thus, arguing 
for an adequate expression of Panx1 in maintaining keratinocyte differentiation.  
1.8.3 Intracellular responses mediated by Panx3 
Keratinocyte and Chondrocyte differentiation: In contrast to Panx1, much less is 
known about the channel capabilities of Panx3. We have shown that, similar to 
Panx1, Panx3 also reduces the proliferation of REKs without altering its migration 
rates [67]. However, unlike Panx1, Panx3 maintains the integrity of the 
organotypic epidermis and keratinocyte differentiation upon its over-expression 
[67]. In addition, Panx3 expression in cartilage has recently been associated with 
chondrocyte differentiation [37]. Specifically, Panx3 promotes ATP release into 
the extracellular medium (likely by the action of Panx3 single membrane 
channels), and reduces the parathyroid hormone-mediated proliferation of 
chondrocytes by decreasing cAMP levels and inhibiting phosphorylation of CREB 
[37]. Thus, these results support a role for Panx3 in switching the fate of 
chondrocytes from proliferation to differentiation.   
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1.9 Distinct from Cx43, Panx1 and Panx3 are glycosylated  
Consensus site analysis of Panx1 and Panx3 polypeptide sequences followed by 
experimental investigation revealed that glycosylation occurs at asparagine 254 
in the second extracellular loop of Panx1 (Figure1.2), and at asparagine 71 in the 
first extracellular loop of Panx3 [25]. Treatment with N-glycosidase F, revealed 
the glycosylation status of Panx1 [25, 47, 59] and Panx3 [25, 59]. Three distinct 
glycosylation species of Panx1 and Panx3 were revealed: the non glycosylated 
form that constitutes the core protein- Gly0 (resolves at ~37 kD for Panx1 and 
~30 kD for Panx3), the predominant ER resident high mannose form- Gly1 
(resolves at ~42-43 kD for Panx1 and ~43 kD for Panx3) and the complex 
glycosylated form that is fully processed- Gly2 (resolves at ~48 kD for Panx1 and 
at ~44-45 kD for Panx3). Glycosylation of pannexins is a post-translational 
modification that is not found on any connexin, including Cx43. Instead, the 
multiple banding profile of Cx43 detected by immunoblotting is due to differential 
states of phosphorylation [80]. Although both Panx1 and Panx3 encode several 
consensus sites for phosphorylation [25], alkaline phosphatase treatment did not 
change the protein banding pattern for either Panx1 or Panx3, unlike Cx43 [25].  
Nevertheless it remains possible that Panxs could serve as a substrate for 
phosphorylation events without causing any shift in the banding profile. 
The extended carbohydrate modifications on the ELs of pannexins have been 
reported to prevent the close docking of single-membrane channels at cell-cell 
appositions, in contrast to the connexons which are never glycosylated. Electron 
micrographs of Panx1 in the areas of apposing cells revealed intercellular 
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spacing of 20-50 nm, which is quite distinct from the 2-4 nm spacing seen in 
Cx43-based gap junctions [47]. The glycosylation status of Panxs has also been 
proposed to be mechanistically inhibitory to gap junction formation. This notion is 
based on the report where removal of all cell surface glycan chains from rat 
Panx1 as well as all other cell surface glycoproteins increased the junctional 
conductance in Xenopus oocytes [81]. Interestingly, the GJ coupling did not 
occur until 6 hours post pairing, which is greatly delayed from paired Oocytes 
that express connexins [47, 81].  
Glycosylation of Panx1 and Panx3 is important for proper trafficking to the cell 
surface. This conclusion is based on reduced [25] or absent cell surface 
localization [47] of the glycosylation-deficient mutants Panx1N254Q or Panx3N71Q. 
Our recent data has shown that a subpopulation of both the N-glycosylation 
deficient mutants of Panx1 and Panx3 that do reach the cell surface are capable 
of forming functional single membrane channels [59],  thus suggesting that 
glycosylation of pannexins mediates their cell surface trafficking, without 
impairing the ability to assemble into functional channels.  Overall, the distinct 
post-translational modification of Panx1 and Panx3 in comparison to Cx43 
separates the pannexin family from the better understood connexin family of 
proteins. While the life cycle aspects of Cx43 are well characterized, our 
knowledge of trafficking events regulating the Panx1 and Panx3 function remains 
poor. 
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1.10 The life cycle of Cx43-from biogenesis to degradation 
1.10.1 Biogenesis of Cx43 
Cx43 has a relatively short half life of approximately 1-3 hours [82]. As a result, 
gap junction channels composed of Cx43 are continually being transported to 
and removed from the plasma membrane. Being an integral membrane protein, 
Cx43 becomes co-translationally inserted into the ER membrane prior to 
oligomerization into connexons [13, 83]. Although several connexins have been 
reported to oligomerize in the ER [84-86], this is not the case for Cx43. Instead, 
Cx43 exist in a monomeric form after exiting the ER, and undergoes 
oligomerization in the trans-Golgi network prior to the cell surface trafficking [87].  
1.10.2 Transport of Cx43 to the plasma membrane 
Time-lapse imaging of the GFP-tagged Cx43 has revealed its delivery to the 
plasma membrane in pleiomorphic vesicles and tubular extensions, originating 
from the distal end of the Golgi apparatus [88]. Transport of Cx43 is also 
facilitated in part by microtubules. This understanding is based on the fact that 
Cx43 gap junction plaques failed to readily regenerate in the presence of 
nocodazole-induced depolymerized microtubules [88]. Interestingly, other reports 
suggest that neither microfilaments nor microtubules are an absolute requirement 
for the assembly of gap junctions; however, intact microtubules are necessary for 
the enhanced growth of gap junctions and Cx43 transport to the plasma 
membrane [89].  The targeting of Cx43 to specific cell surface micro-domains, 
however, remains relatively unclear with some evidence supporting a role for 
adherens-based junctions in the formation of gap junctions [90, 91]. 
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Once at the cell surface, connexons were originally proposed to exist in a gated-
closed state to avoid unwanted exchange of small molecules with the 
extracellular environment [13]. However, this notion is currently evolving as 
several lines of evidence supports the role of unpaired connexons, otherwise 
called hemichannels, in non-junctional plasma membranes for the intercellular 
communication through paracrine signaling [92, 93].  
1.10.3 Assembly of Cx43 gap junctions at the cell 
surface 
At the cell surface, connexons from two adjacent cells dock to form gap junction 
channels that tightly cluster into gap junction plaques [13]. Studies using 
tetracysteine and GFP-tagged Cx43 supported a model in which new gap 
junctions formed at the outer edge of the plaques, with mature channels 
coalescing at the center of the plaques [94, 95]. Cx43 was documented to cluster 
into gap junction plaques through lateral movements [88]. Fluorescence recovery 
after photobleaching (FRAP) revealed two states of Cx43 lateral mobility, high 
and low [96]. The differential rates of Cx43 mobility was proposed to be either 
due to scaffolding with binding partners, and/or acquiring different states of 
channel packing-ranging from loose (new) to crystalline (mature) structures [96]. 
Electron microscopy images of Cx43 containing fragments budding from the 
inner segment of gap junction plaques further support the mature aspects of the 
gap junction being destined for internalization and degradation [94]. 
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1.10.4 Internalization and degradation of Cx43 
Several electron microscopic studies have reported the internalization of 
connexons into one of the two neighboring cells in the forms of double-
membrane structures [97-100], recently coined connexosomes [13].  Micro-
injection studies with anti-Cx43 antibody, together with rapid time-lapse imaging 
revealed connexosomes to originate from pre-existing gap junction plaques and 
internalize in one of the two adjacent cells [101]. Furthermore, a close 
association of Cx43 double-membrane structures to clathrin-coated pits and actin 
cytoskeleton [102-104] suggests additional mechanisms may be involved in 
Cx43- gap junction internalization.  
Once internalized, degradation of Cx43 is mediated by both lysosomes and 
proteasomes [105, 106]. Evidence suggests that mono-ubiquitination of Cx43 
serves as an internalization cue, whereas poly-ubiquitination directs it to the 
lysosomes [107]. Alternatively, it is hypothesized that proteasomal-mediated 
degradation of Cx43 might be correlated with ER-associated degradation (ERAD) 
of mis-folded proteins, while lysosomes function to degrade Cx43 removed from 
the plasma membrane [13].  
Although Cx43 is well characterized from biogenesis to degradation, an in-depth 
knowledge of the life cycle of pannexins remains obscure.  
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1.11 Rationale, Hypothesis and Objectives of the Thesis 
1.11.1 Rationale 
Ever since the discovery of pannexins, considerable focus has been given 
towards understanding the function of these channels and their physiological 
roles; however, trafficking events that regulate the overall function of pannexins 
are not fully understood. Although pannexins and connexins were reported to 
share structural similarities [1, 108], it was not clear if pannexins exhibit 
characteristics similar to connexins in terms of their plasma membrane delivery 
and localization, cell surface mobility dynamics, interplay with the cytoskeletal 
network and pathways governing their turnover and degradation. Therefore, we 
paralleled our study to the well-characterized life cycle of Cx43. For our studies 
we mainly utilized Cx43 positive BICR-M1Rk, (rat mammary tumor) cell line as 
these cells are devoid of Panx1 and Panx3 expression, and have previously 
proven to be an excellent reference model for characterizing the trafficking, 
assembly and turnover of Cx43 [96, 109]. BICR-M1Rk cells can also be readily 
engineered to express either Panx1 or Panx3.  
1.11.2 Hypothesis 
I hypothesize that in comparison to Cx43, Panx1 and Panx3 exhibit distinct 
subcellular distributions, cell surface motilities and cytoskeletal dependencies; 
while Panx1 is further governed by unique turnover dynamics and mechanistic 
pathways that lead to its internalization and degradation. 
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1.11.3 Objectives (Figure 1.3) 
Objective 1 (Chapter 2)  To characterize the subcellular distribution of Panx1 
and Panx3, to identify the secretory pathway involved in Panx1 and Panx3 cell 
surface trafficking, to analyze the mobility dynamics of GFP-tagged Panx1 and 
Panx3 at the cell surface and to assess the role of the cytoskeleton in Panx1 
trafficking and cell surface dynamics. 
Objective 2 (Chapter 3) To identify the role of the carboxyl terminal tail in 
Panx1 trafficking and homomeric interactions.  
Objective 3 (Chapter 4) To explore the pathways for Panx1 internalization and 
degradation 
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Figure 1.3 Schematic representation of the aims addressed in the study  
Aim#1: To characterize the subcellular distribution profile of Panx1 and Panx3, 
to identify the secretory pathway involved in Panx1 and Panx3 cell surface 
trafficking, to analyze the mobility dynamics of GFP-tagged Panx1 and Panx3 at 
the cell surface to assess the role of the cytoskeleton in Panx1 trafficking and cell 
surface dynamics. Aim #2: To identify the role of carboxyl terminal tail in Panx1 
trafficking and homomeric interactions. Aim #3: To explore pathways for Panx1 
internalization and degradation.  
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CHAPTER 2: Pannexin1 and Pannexin3 Delivery, Cell 
Surface Dynamics, and Cytoskeletal Interactions 
 
2.0 OVERVIEW 
 
This study was designed to determine if Panx1 and Panx3 exhibit unique 
characteristics (trafficking, cell surface dynamics and interplay with the 
cytoskeletal network) or are similar to the well studied gap junction protein, Cx43.  
 
 
 
 
 
 
 
 
_____________________ 
This chapter has been published:  
Bhalla-Gehi, Ruchi ; Penuela, Silvia ; Churko, Jared M ; Shao, Qing ;  
Laird, Dale W; Pannexin1 and pannexin3 delivery, cell surface 
dynamics, and cytoskeletal interactions. J Biol Chem, 2010. 285(12): p. 9147-60. 
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2.1  INTRODUCTION 
The pannexin family is a new class of integral membrane glycoproteins that have 
been identified to share sequence homology to the invertebrate gap junction 
proteins, innexins [1]. Unlike the connexin family that is comprised of 21 
members [110], both the human and mouse genomes contain only three 
pannexin-encoding genes (Panx1, Panx2 and Panx3) [1]. Although connexins 
and pannexins exhibit no sequence homology, pannexins are predicted to share 
similar topology to connexins which includes four transmembrane domains, two 
extracellular loops, a cytoplasmic loop and intracellular amino and carboxy 
terminals [21, 25, 47]. Our previous study has shown that ectopically expressed 
Panx1 and Panx3 are capable of trafficking to normal rat kidney (NRK) cell 
surfaces; however, their distribution profile at cell-cell interfaces is not typically 
clustered or punctate as seen for Cx43 [25]. Consistently, electron micrographs 
of Panx1 over-expressing Madin-Darby Canine Kidney cells also revealed 
dispersed Panx1 localization at the plasma membrane with no evidence of gap 
junction plaques [47]. 
Cx43 has a relatively short half-life of approximately 1-3 hours [82].  As a result, 
Cx43 subunits assembled into connexons within the trans Golgi network [87] are 
constantly being transported to and removed from the plasma membrane [88]. 
Recent reports provide evidence that although Panx1 appears to form similar 
hexameric channel units defined as pannexons [47], they exhibit slower turnover 
dynamics in comparison to Cx43, as assessed by the use of pharmacological 
blockers of protein synthesis and protein trafficking [25, 47]. Functionally, most 
30 
 
studies support the premise that pannexins, in particular Panx1, form single 
membrane channels [25, 47, 50, 71, 111, 112], while far less evidence supports 
the notion that they also can form intercellular channels [26, 53]. 
The delivery of Cx43 for the assembly of functional channels at the cell surface 
has been extensively studied using fluorescent protein and epitope tags [94, 96]. 
Cx43-GFP has been shown to exhibit similar distribution and functional 
characteristics as its untagged counterpart, when assessed by dye permeability 
and electrical conductance [88, 113]. Likewise, GFP tagging of the carboxyl 
terminal tail of Panx1 did not significantly alter the localization profile of Panx1 in 
NRK cells [25]. However, a recent electrical conductance assessment provided 
evidence that mouse Panx1-GFP exhibits reduced channel function when 
expressed in human embryonic cells (HEK) 293 cells [114], suggesting that its 
functional state is somewhat impaired but not completely eliminated by the GFP 
tag. In other studies, untagged and tetracysteine-tagged Panx1 exhibited 
comparable capabilities in rescuing the trafficking of the glycosylation-defective 
mutant of Panx1 in Madine-Darby canine kidney cells [81].  Collectively, these 
studies would suggest that the trafficking and life cycle properties of Panx1 can 
be assessed by GFP tagging approaches in conjunction with real-time dynamic 
imaging. 
It has been previously established through a number of studies using both 
untagged and GFP-tagged Cx43 that the delivery and regeneration of Cx43 gap 
junction plaques is facilitated by microtubules and requires a fully functional 
secretory pathway [88, 89, 95]. Other studies using rapid time-lapse imaging of 
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GFP and tetracysteine tagged Cx43 have shown that Cx43 is delivered in 100-
150 nanometer vesicles that coalesce laterally into the pre-existing gap junction 
plaques [94, 115]. However, the delivery of pannexins to the cell surface, their 
dynamic organization at specific cell surface micro-domains, and their 
dependency on an intact cytoskeletal network, have yet to be investigated. 
The life-cycle of Cx43 is governed, in part, by many direct and indirect binding 
partners [13, 44, 116], while pannexin binding partners are only beginning to be 
identified with some evidence to support Panx1 interaction with a protein subunit 
of the voltage-dependent potassium channel [117] and regulatory cross-talk with 
P2X7 receptors [49, 111].  In the present study we further expand on a very 
limited number of pannexin binding proteins by identifying actin as a specific 
Panx1 binding protein. 
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2.2 EXPERIMENTAL PROCEDURES 
2.2.1 Cell Culture and Reagents 
BICR-M1Rk cells originally derived from a rat mammary tumor,  HEK-293T, NRK 
and REK (rat keratinocytes) cells were cultured in high glucose DMEM 
(Invitrogen, Burlington, ON, Canada), supplemented with 10% fetal bovine 
serum, 100 units/ml penicillin, 100 µg/ml streptomycin, and 2 mM L-glutamine (all 
from Invitrogen, Burlington, ON, Canada). B16-BL6 murine melanoma cells were 
kindly provided by Dr. Moulay A. Alaoui-Jamali-(Department of Medicine and 
Oncology, McGill University; Montreal, Canada) and cultured as previously 
described [118]. Trypsin (0.25%, 1mM EDTA), Opti-MEM1 media and 
Lipofectamine 2000 were purchased from Invitrogen. Brefeldin-A (BFA), 
nocodazole and cytochalasin B were purchased from Sigma-Aldrich (Oakville, 
ON, Canada).  
2.2.2 Expression Constructs of Mouse Panx1, Panx2, 
and Panx3 and Engineering of the GST-Panx1 
Carboxyl domain   
Untagged and GFP-tagged expression constructs encoding full length mouse 
Panx1 and Panx3 were previously described [25], and correspond to current 
NCBI reference sequence encoding 426 amino acids for Panx1 (NP_062355) 
and 392 amino acids for Panx3 (NP_766042).  
As previously described, Panx2 was originally cloned from mouse brain and the 
purified PCR product was inserted into the EcoR1-Sal1 site of pEGFP-N1 vector 
(Clonetech, CA) to generate the untagged Panx2 [59]. The sequence was 
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confirmed to encode 677 amino acids according to RefSeq. Furthermore, Panx2 
cDNA was amplified using forward primer: 5’- CCCAAGCTTATGCACCACCTC to 
create a HindIII site and 5’- GGCGACCGGTCCAAACTCCACA to create a AgeI 
site at the 5' and 3' ends of Panx2, respectively. PCR products and the vector 
pEGFP-N1 (Clonetech, Palo Alto, CA) were digested with HindIII and Age1, 
ligated and clones were selected. GFP was fused in frame to the carboxyl 
terminus of Panx 2 with the addition of a five-amino acid polylinker 
(GGACCGGTCGCCACC) and validated by sequencing.  
Panx1 carboxy tail primers (Forward 5’- CTAGGATTCCGGCAGAAAACGGAC, 
Reverse 5’- CGAGTCGACTTAGCAGGACGGATT), with flanking sites for BamHI 
and SalI amplifying the Panx1 carboxy tail sequence (corresponding to amino 
acid 299-426), were created.  This sequence was ligated into the pGEX-6P-3 
GST vector and transformed into BL21 bacteria.  Batch purification using 
Sepharose 4B was performed as described in GST Gene Fusion System manual 
with some modifications (GE Healthcare, Buckinghamshire, UK).  A single BL21 
clone transformed with either GST alone or GST-Panx1 carboxyl tail was grown 
to absorbance (600nm) of 1 and was induced by the addition of 0.5 mM isopropyl β-
D-1-thiogalactopyranoside. A total of 500 mL of either GST or GST-Panx1 
carboxy tail bacterial culture was shaken overnight at room temperature. The 
next day purification was performed using 400 µL of 50% sepharose slurry, 
washed in PBS seven times and stored at 4oC for the co-sedimentation assays. 
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2.2.3 Transfection and Engineering of Stable Cell Lines  
DsRed tagged Sar1WT and Sar1H79G cDNA constructs were previously described 
[88] and used for transfection into BICR-M1Rk cells engineered to express Panx1 
or Panx3. Briefly, BICR-M1Rk cells were grown overnight to 50-70% confluency 
on glass coverslips and transfected in Opti-MEM1 media containing 4 μL of 
Lipofectamine 2000 and 1 µg of Panx1 or 3 µg of Panx3 plasmid DNA together 
with 2 µg of Sar1WT or Sar1H79G expression constructs.  
Panx1-GFP cDNA construct was previously described (5) and used to transfect 
BICR-M1Rk cells stably expressing untagged Panx1, and B16-BL6 cells. Cells 
were grown overnight to 50-70% confluency on 35mm glass bottom dishes and 
transfected in Opti-MEM1 media containing 1.5 μL of Lipofectamine 2000 and 1.5 
µg of Panx1-GFP plasmid DNA for 4 hours at 37°C. 
For Panx3 and Panx3-GFP co-transfections: BICR-M1Rk cells were grown 
overnight to 20-30% confluency on 35mm glass bottom dishes and transfected in 
Opti-MEM1 media containing 4 μL of Lipofectamine 2000 and 3 μg of Panx3 
together with 1.5 μg of Panx3-GFP plasmid DNA. Opti-MEM1 media was 
replaced with complete culture media 4 hours after transfection at 37 ˚C. 
For Panx2 and Panx2-GFP expression: BICR-M1Rk cells grown overnight to 50-
70% confluency on glass coverslips were transfected in Opti-MEM1 media 
containing 3 μL of Lipofectamine 2000 and 1.5 μg of Panx2 or 1.5 μg of Panx2-
GFP plasmid DNA. For co-transfection of Panx2 with Panx2-GFP 0.75 μg of 
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each plasmid DNA was used in Opti-MEM1 media containing 3 μL of 
Lipofectamine 2000.  
Full length constructs encoding mouse Panx1, Panx1-GFP and Panx3 were 
inserted into the AP-2 retroviral vector and transfected into the 293GPG 
packaging cell line as described earlier by Qin et al. [119]. Following transfection, 
replication-defective retroviral supernatants were collected and filtered through a 
0.45 μm filter (Pall Gelman Laboratories, Ann Arbor, MI). BICR-M1Rk cells 
expressing Cx43-GFP were engineered to stably express Panx1 and Panx3 by 
following a previously described protocol [119]. Retrovirus encoding Panx1-GFP 
was also used to stably express GFP-tagged Panx1 in BICR-M1Rk cells.  
2.2.4 Treatments with pharmacological reagents  
Panx1 and Panx3 over-expressing BICR-M1Rk cells were treated with 5μg/mL of 
BFA for 19 hours at 37˚C, and cell lysates were collected and subjected to 
immunoblotting. For elucidating the role of cytoskeletal elements in pannexin 
trafficking, Panx1-GFP expressing cells were treated with 10μM nocodazole or 
2.5 μg/mL cytochalasin B for 90 minutes at 37˚C and fixed for 
immunocytochemistry. For fluorescence recovery after photobleaching (FRAP) 
studies, Panx1-GFP expressing cells were pre-treated with cytoskeletal inhibitors 
for 90 minutes prior to imaging up to 3-4 hours in presence of these same 
inhibitors.  
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2.2.5 Immunocytochemistry 
Cells were immunolabeled as previously described [25].  Briefly, cells grown on 
glass coverslips were fixed using ice-cold 80% methanol and 20% acetone for 20 
minutes at 4˚C. Cytochalasin B-treated cells were fixed using 3.7% formaldehyde 
for 30 minutes at room temperature and permeabilized for 45 minutes in a 1% 
blocking solution (Bovine Serum Albumin-(BSA; Sigma))  containing 0.1% Triton-
X-100. Cells were incubated with a 500-fold dilution of polyclonal anti-Cx43 
antibody (Sigma), a 100 fold dilution of polyclonal anti-GPP130 antibody 
(Convance), polyclonal anti-Panx2 antibody (Zymed Laboratories, San 
Francisco, CA) or monoclonal anti-tubulin antibody (Convance) for 1 hour at 
room temperature. Affinity-purified polyclonal Panx1 and Panx3 antibodies were 
used at a concentration of 2 μg/mL. F-actin was localized using a 200 fold 
dilution of rhodamine phalloidin (Invitrogen). Cells were incubated in goat anti-
rabbit antibody conjugated to Texas Red or fluorescein isothiocyanate (FITC) 
(1:100, Jackson Laboratories, Westgrove, PA) or a goat anti-mouse antibody 
conjugated to Texas Red (1:100, Jackson Laboratory). Cells were rinsed with 
PBS and nuclei were stained with Hoechst 33342 and mounted. Immunolabeled 
cells were imaged using a 63x oil objective lens mounted on a Zeiss LSM 510 
META (Zeiss, Toronto, ON) system. 
2.2.6 Immunoblotting and Co-immunoprecipitation 
Cell lysates from BICR-M1Rk cells transiently co-transfected with Sar1 and Panx1 
or Panx3 cDNA constructs, and BFA-treated cells were collected using a lysis 
buffer containing 1% Triton-X-100, 10 mM Tris, 150 mM NaCl, 1 mM EDTA, 1 
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mM EGTA, 0.5% NP-40, 100 mM sodium fluoride and 100 mM sodium 
orthovanadate and a protease inhibitor tablet (one tablet per 10 mL buffer; 
Roche, Laval, QC), pH 7.4.  Protein concentrations were measured using a BCA 
protein determination kit (Pierce). In total, 20-30 µg of protein was resolved using 
10% SDS-PAGE and transferred to nitrocellulose membrane (Pall Life Sciences, 
NY). Nitrocellulose membranes were blocked in Licor blocking solution (Lincoln, 
NE) or 3% BSA solution, and probed overnight with polyclonal affinity purified 
anti-Panx1 or anti-Panx3 antibodies (0.2 µg/mL) at 4˚C. Monoclonal anti -β-actin 
antibody (1:5000, Sigma) was used to assess gel loading. Detection of primary 
antibody binding was performed by using mouse IgG IR dye 800 (Rockland 
Immunochemicals, PA) and rabbit IgG Alexa 680 (Invitrogen) with Odyssey 
infrared imaging system (Licor).  
For co-immunoprecipitation experiments, 1 mg of protein lysates from WT, Panx1 
and Panx1-GFP over-expressing BICR-M1Rk cells were incubated overnight at 
4°C in the lysis buffer (1% Triton-X-100, 10 mM Tris, 150 mM NaCl, 1 mM EDTA, 
1 mM EGTA, 0.5% NP-40, 1 mM sodium fluoride and 1mM sodium 
orthovanadate containing 10 µg/mL of anti-Panx1 antibody. The antibody 
complex was pulled down with 30 µl of pre-cleaned protein A-sepharose beads 
(in PBS) for 2 hours on the rocker at 4°C. The antibody-bead complex was 
centrifuged at 4500 RPM at 4°C for 2 minutes and supernatant was aspirated. 
Unbound nonspecific protein was separated from bound proteins by washing 
three times with 500 µL of lysis buffer, and the bound complex was detached by 
boiling for 5 minutes in 30 µL of 2x Laemmli loading sample buffer containing β–
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mercaptoethanol. Samples were resolved by 10% SDS-PAGE and transferred to 
nitrocellulose membranes which were probed with anti-Panx1 and anti-β-actin 
antibodies. 
2.2.7 FRAP analysis 
To assess Panx1 or Panx3 dynamics at the cell surface, BICR-M1Rk cells 
expressing Panx1-GFP alone or in combination with the untagged, Panx1, or 
Panx3-GFP together with Panx3, were cultured on 35 mm glass bottom dishes 
and subjected to FRAP. B16-BL6 cells expressing Panx1-GFP were also subject 
to FRAP analysis. Rapid time-lapse imaging was performed on a Zeiss LSM 510 
META to quantify the movement of Panx1-GFP into the bleached region of 
interest (ROI), as previously described [96].  Briefly, glass bottom dishes were 
placed in an environmentally-controlled chamber and ROIs representing the 
various plasma membrane domains were selected and photo-bleached using 
scan iterations at 488 nm with 100% laser strength. Images were acquired ~2-5 
seconds apart for up to 60 seconds with 0.9% laser strength, to avoid further 
photobleaching. Fluorescence intensities within ROIs were quantified as 
previously described [96]. Briefly, fluorescence recovery was recorded: before 
photobleaching, immediately upon completion of photobleaching (t was set to 0 
seconds), and post bleaching at the following time intervals (15, 25, 50 and 60 
seconds). Post-bleach intensities were corrected and normalized for any residual 
fluorescence, and the recoverable fraction of Panx1-GFP or Panx3-GFP was 
calculated using FNt= (Ft – F0)/ (Fi - F0) as previously described [120]; where FNt = 
normalized fluorescence at a t time point; Ft = fluorescence intensity within ROI at 
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t seconds post photo-bleach; F0 = fluorescence intensity upon photo-bleaching at 
t = 0 and Fi = fluorescence intensity prior to photobleaching. All FRAP 
experiments were repeated 3 times for each experimental set, with each set 
containing multiple ROIs at t = 15, 25, 50 and 60 seconds. FNt values from 
replicates of each experimental set were combined and a non-linear regression 
analysis was performed to obtain a curve of best fit using GraphPad Prism 
software (San Diego, CA). To compare the mobility dynamics of Panx1-GFP or 
Panx3-GFP in various plasma membrane domains, a one-way ANOVA followed 
by Tukey’s multiple comparison tests were performed. For comparisons between 
untreated versus nocodazole and cytochalasin B treated experimental sets, t 
tests were performed using GraphPad Prism software.  
2.2.8 Vesicle Movement  
Panx1-GFP containing vesicles were analyzed by measuring the total distance 
traveled of vesicles that remained in confocal plane of focus for the duration of 
the analysis.  Vesicles of ~0.5-0.8 μm in diameter were monitored by 1.8 second 
interval image scans for a total period of 8.8 seconds. (n= 18-20, over 4 
independent repeats).  
2.2.9 Actin co-sedimentation assays  
Muscle actin (Cytoskeleton Inc., Denver, CO) was resuspended in buffer (5 mM 
Tris-HCl pH 8.0, 0.2 mM CaCl2) to a concentration of 1 mg/mL in 250 µl on ice for 
30 min. 25 µLs of 10X actin polymerization buffer (500 mM KCl, 20 mM MgCl2, 
10 mM ATP, 100 mM Tris pH 7.5) was added to the monomeric actin and 
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incubated at room temperature for 1h (F-actin stock at 23 µM).  Protein samples 
of BSA, GST, Panx1 C-tail and GST tagged Panx1 C-tail were centrifuged at 
150,000 x g for 1 h at 4 ºC. Supernatants were collected and placed on ice. For 
co-sedimentation assays, a GST fusion protein containing the C-tail of mouse 
Panx1 was used, either as a fusion protein after elution from the sepharose 
beads or after cleavage of the Panx1 C-tail from the fusion protein using 
PreScission Protease (GE Healthcare, Buckinghamshire, UK) for 16 h at 4 ºC, as 
per manufacturer's instructions.  Following the Cytoskeleton Inc. protocol for actin 
binding protein assays, 50 µL samples were prepared with either F-actin alone, 
GST protein with or without F-actin, BSA (negative control) plus F-actin, and 
Panx1 C-tail or GST fusion protein with or without F-actin.  Samples were 
incubated at room temperature for 30 min, followed by centrifugation at 150,000 
x g for 1.5 h at 24 ºC. Supernatants were carefully removed and mixed with 10 
µL 4X Laemmli reducing-sample buffer. The pellets were resuspended in 30 µL 
of double-distilled water and mixed with 30 µL of 2X Laemmli buffer.  Equal 
volumes of resuspended pellets and supernatants were run in duplicate on 10% 
SDS-PAGE.  Gels containing samples were either stained overnight with Sypro-
Ruby Protein gel stain (Invitrogen) or transferred onto nitrocellulose membranes 
using an iBlot apparatus for dry transfer (Invitrogen). Sypro-Ruby stained gels 
were de-stained and exposed to UV for visualization of the major bands. 
Nitrocellulose membranes were incubated overnight with primary anti-Panx1 
antibodies, washed, and probed with Alexa-680 anti-rabbit secondary for 
detection of Panx1 bands with a LiCor scanner as described previously [25]. 
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2.2.10 Biotinylation assays 
BICR-M1Rk cells grown on 100 mm dishes were transiently transfected with 5-10 
µg of Panx3-GFP encoding cDNA constructs, and 48 hours post transfection, 
cells expressing Panx3-GFP were subjected to biotinylation treatment on ice as 
previously described [25]. Cells were incubated in PBS or with cold PBS 
containing EZ-link Sulfo NHS-LC-biotin (0.5 mg/mL; Pierce Biotechnology) for 20 
min at 4oC.  Control and biotin-treated cells were washed and incubated in 100 
mM glycine buffer for 15 min at 4oC to quench the biotin.  Cells were then lysed 
with SDS lysis buffer (1% Triton X-100 and 0.1% SDS in PBS) and protein 
concentrations were measured using a BCA protein determination kit (Pierce). In 
total, 1000 µg of protein from control and biotin-treated cell lysates were rocked 
overnight at 4oC in the presence of 50 μL of neutravidin-agarose beads (Pierce 
Biotechnology).  Beads were washed three times with immunoprecipitation lysis 
buffer (IP)  (150 mM NaCl, 10 mM Tris-HCl, pH 7.4, 1 mM EDTA, 0.5% NP-40, 
and 1% Triton X-100) containing 1 mM NaF and 1 mM Na3VO4; and once with 
PBS containing 1 mM NaF and 1 mM Na3VO4. The beads were air dried and 
resuspended in 50 μL of 2x Laemmli loading sample buffer containing β–
mercaptoethanol before boiling for 5 minutes.  As a lysate control, 40 μg of total 
protein from control and biotin samples was also resolved by SDS-PAGE and 
transferred to nitrocellulose membranes for immunoblotting with anti-Panx3 
antibody.  GAPDH was used as a control to detect any unexpected biotin 
internalization. 
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2.3 RESULTS 
We have previously shown that the Cx43-positive BICR-M1Rk (rat mammary 
tumor) cell line is an excellent reference model for investigating dynamic delivery 
events, assembly and turnover mechanisms of Cx43 [96, 109]; therefore, we 
designed our experimental approach to compare Panx1 and Panx3 trafficking 
dynamics in Cx43-positive BICR-M1Rk cells.  We engineered stable cells lines to 
ectopically express Panx1 or Panx3. Western blots analysis revealed that wild-
type BICR-M1Rk cells are negative for Panx1 and Panx3 (Figure 2.1A) but when 
engineered to express pannexins, Panx1 resolved as multiple species ranging 
from ~41-48 kDa; whereas, Panx3 was detected as a doublet at ~43kDa  (Figure 
2.1A). These multiple pannexin species have previously been shown to be the 
result of glycosylation [25, 47]. Immunolabeling of both Panx1 and Panx3 
revealed that both of these pannexins were capable of trafficking and localizing in 
a relatively uniform pattern at the apposing cell surface (Figure 2.1B). In contrast, 
detectable Panx2 and Panx2-GFP were mainly localized in the intracellular 
compartments of, not only BICR-M1Rk cells, but also in HEK 293T, NRK and rat 
keratinocytes (Supplementary Figure 1). Not unexpected, the co-expression of 
Panx2 with Panx2-GFP did not alter the distribution pattern of untagged or 
tagged Panx2. These studies indicate that Panx2 has a unique distribution when 
compared to Panx1 and Panx3 even when expressed in the same reference 
cells.   
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Figure 2.1 Panx1 and Panx3 are capable of trafficking to the cell surface in 
BICR-M1Rk cells 
BICR-M1Rk cells were engineered to stably express Panx1 or Panx3. 
Immunoblotting with affinity purified antibodies (anti-Panx1 and anti-Panx3) 
revealed multiple banding profiles of Panx1 (~41-48 kDa) and Panx3 (~41-43 
kDa) (A). β-actin was used as a protein loading control (A).  Immunolabeling of 
Panx1 and Panx3 (B) identified that both pannexins trafficked and localized to 
the cell surface (arrows). Nuclei are stained with Hoechst 33342 (blue).  Bars= 10 
µm. Representative of three independent experiments. 
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2.3.1 Trafficking of Panx1 and Panx3 is mediated 
through Sar1-dependent COPII vesicles 
It has been widely documented that Sar1 (secretion associated and Ras related) 
GTPase is critical for COPII (coat protein II) assembly and vesicular transport of 
newly synthesized proteins from the endoplasmic reticulum (ER) compartment 
[121, 122]. Dominant-negative GTP-bound mutant Sar1H79G has previously been 
shown to block the ER-Golgi transport of newly synthesized Cx43 in BICR-M1Rk 
cells [88]. In order to determine if Panx1 and Panx3 follow the classical ER-Golgi 
secretory pathway mediated through a COPII-dependent mechanism, we 
engineered BICR-M1Rk cells to co-express Panx1 or Panx3 along with Sar1WT or 
Sar1H79G. Co-expression of Panx1 with Sar1WT revealed a typical uniform 
distribution of Panx1 at the cell surface (Figure 2.2A, arrows), while Sar1WT was 
localized to the paranuclear region in an intact Golgi-like compartment (Figure 
2.2A, B). In comparison, expression of Sar1H79G resulted in fragmentation of a 
Golgi-like compartment in the paranuclear region (Figure 2.2A, B); and retention 
of Panx1 and Panx3 in ER-like patterns with little evidence of cell surface 
localization (Figure 2.2A, B arrowheads). In the same culture environments, 
BICR-M1Rk cells expressing Panx1 or Panx3 but not Sar1H79G revealed a uniform 
cell surface labeling of Panx1 and Panx3 (Figure 2.2A, B inserts, arrows). 
Furthermore, as we previously reported [88], the distribution of Cx43 gap junction 
plaque-like structures was not evident in the presence of Sar1H79G (not shown). 
Since Panx1 and Panx3 resolve as multiple bands (Figure 2.1A and 2C), we 
wanted to determine the effect of dominant-negative Sar1 on the different 
molecular species. 
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Figure 2.2 Trafficking of Panx1 and Panx3 was disrupted in the presence of 
a dominant-negative Sar1 mutant 
BICR-M1Rk cells expressing Panx1 or Panx3 together with Sar1WT or Sar1H79G 
were immunolabeled for Panx1 (A) or Panx3 (B). Both Panx1 and Panx3 were 
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capable of trafficking and localizing to the cell surface in the presence of Sar1WT 
(A, B filled arrows). Expression of Sar1H79G resulted in Panx1 and Panx3 being 
retained in an ER-like compartment (A, B arrowheads); however, when cells 
expressed Panx1 or Panx3 without expressing Sar1H79G in the same cellular 
environment, both Panx1 and Panx3 trafficked to the plasma membrane (A, B, 
insets, arrows). Western blotting of Panx1 and Panx3 in the presence of Sar1H79G 
(C), or after long term BFA treatment (19hr; D) revealed an accumulation of the 
high mannose species of Panx1 and Panx3, with a noticeable reduction in the 
higher molecular weight glycosylation species (C and D). Nuclei are stained with 
Hoechst 33342 (blue).  Bars= 10 µm. Representative of three independent 
experiments. 
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When compared to Panx1 alone or with Sar1WT, the presence of Sar1H79G 
revealed an accumulation of the intermediate species (previously demonstrated 
to be a high mannose glycosylation species [47]), with a noticeable reduction in 
the most extensively glycosylated species of Panx1 (Figure 2.2C). Similarly, an 
accumulation of lower molecular weight species (previously reported to be a high 
mannose glycosylation species [59]) of the Panx3 doublet was also revealed in 
the presence of Sar1H79G (Figure 2.2C), suggesting that the higher molecular 
weight species of Panx1 and Panx3 is the consequence of additional post-
translational processing  that occurs upon exiting the ER. Consistently, long term 
brefeldin A (BFA) treatment (19hr) (a pharmacological blocker known to inhibit 
anterograde transport of proteins between the ER and Golgi apparatus [123]) of 
Panx1 and Panx3 expressing BICR-M1Rk cells caused a detectable increase in 
the high mannose species of Panx1 and Panx3, with a noticeable reduction in 
the higher molecular weight species of both Panx1 and Panx3 (Figure 2.2D). 
Collectively, these results suggests that both Panx1 and Panx3 are co-
translationally inserted into the ER and transported in a COPII-dependent 
mechanism to the Golgi apparatus, where they are substrates for further 
glycosylation and processing.  
2.3.2 GFP-tagged Panx1 mimics the distribution profile 
of untagged Panx1 and is suitable to investigate the 
dynamic distribution of Panx1 
In order to assess the dynamic properties of Panx1, we first stably expressed 
Panx1-GFP in BICR-M1Rk cells and evaluated its distribution profile with respect 
to untagged Panx1. Immunofluorescent labeling revealed that Panx1-GFP 
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exhibited a similar cell surface distribution pattern (Figure 2.3A, arrows) as 
observed for untagged Panx1 (Figure 2.3F, arrows), with a notable increase in 
intracellular fluorescent signal (Figure 2.3A). Clearly, the cell surface pattern for 
Panx1-GFP was distinct from that observed for Cx43-GFP when expressed in 
the same cell type (Figure 2.3A, insert). To assess the dynamic activity of Panx1 
at the cell surface and within intracellular compartments we performed rapid 
time-lapse imaging on cells that expressed Panx1-GFP.  Panx1-GFP was not 
only visualized in a relatively uniform pattern at the cell surface (Figure 2.3A), but 
also as mobile bright fluorescent clusters (Figure 2.3B and C). Rapid time-lapse 
imaging revealed that these clusters (suggestive of Panx1-GFP aggregates) 
were mobile at the plasma membrane and in regions devoid of cell-cell contacts 
(Figure 2.3B and C, filled arrows, see Movie 2.1). In addition, Panx1-GFP was 
also found in distinct intracellular vesicle-like structures that were highly mobile 
(Figure 2.3D, unfilled arrows, Movie 2.1). Surprisingly, and distinct from that 
observed for functional Cx43, Panx1-GFP was found in dynamic finger-like 
projections indicative of membrane protrusion (Figure 2.3E, arrowheads, Movie 
2.1). This localization to membrane protrusion was also frequently evident in cells 
expressing untagged Panx1, suggesting that this localization profile is not a 
consequence of the GFP tag (Figure 2.3F, arrowheads). 
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Figure 2.3 Panx1 was localized to multiple sites, compartments and 
microdomains 
 
Immunolabeling of Panx1-GFP with an anti-Panx1 antibody revealed its 
localization at the cell surface (A, filled arrows) in a pattern that was distinct from 
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Cx43-GFP (A, insert). Regions of interest from live BICR-M1Rk cells expressing 
Panx1-GFP (B, red and blue rectangles) were chosen for live imaging and 
imaged at t= 0, 10, 50, 70 and 110 seconds (C and D). Rapid time-lapse imaging 
revealed that Panx1-GFP is distributed primarily in a uniform pattern, while 
mobile bright fluorescent clusters could be identified at the cell surface (B and C, 
filled arrows) and within the cell (D, unfilled arrows). Panx1-GFP was clearly 
localized to dynamic plasma membrane protrusions (E, arrowheads), that were 
evident in BICR-M1Rk cells expressing untagged Panx1 (F, arrowheads). Nuclei 
in A and F are stained with Hoechst 33342 (blue).   Bars= 10µm. Representative 
of three independent experiments. See Movie 2.1: http://www.jbc.org/  
Movie 2.1 Dynamic structures carrying Panx1-GFP are distributed 
intracellularly and at the cell surface 
Rapid time-lapse imaging was performed on Panx1-GFP expressing BICR-M1Rk 
cells to assess the overall localization and distribution pattern of Panx1.  Panx1-
GFP was localized in a relatively uniform manner at the cell surface with some 
evidence of cell surface clusters. Intracellular vesicle-like structures carrying 
Panx1-GFP were evident as bright clusters. Panx1-GFP was also localized to 
membrane protrusions that were constantly being remodeled. The movie 
sequence represents 32 frames scanned every 5 seconds, with a total elapsed 
time of 160 seconds. 
 
 
 
 
51 
 
2.3.3 Panx1-GFP is highly mobile at all plasma 
membrane domains as revealed by FRAP analysis 
To analyze the dynamic mobility characteristics of Panx1-GFP, we first assessed 
the ability of Panx1-GFP to traffic and localize at three distinct plasma membrane 
domains where there was no neighboring cell (Figure 2.4A, red arrow), the 
neighboring cell expressed Panx1-GFP (Figure 2.4A, blue arrow), or the 
neighboring cell was devoid of Panx1-GFP (Figure 2.4A, purple arrow).  Once it 
was determined that Panx1-GFP was not differentially distributed to any of these 
cell surface domains (Figure 2.4A), regions of Panx1-GFP located at these 
distinct domains were selected and subjected to fluorescence recovery after 
photobleaching (FRAP) analysis (Figure 2.4B-E). After initial photobleaching, 
within 2 seconds there was a rapid movement of fluorescent molecules from the 
outer edges into the photobleached area of all bleached cell surface domains 
(Figure 2.4B-D, inserts).  FRAP curve analysis revealed the mobile fluorescent 
fractions to be 45-60% at all micro-domains over a time course of only 60 
seconds (Figure 2.4E). Moreover, there was no significant difference in the total 
recovered fraction of Panx1-GFP within any of the plasma membrane domains; 
an observation that was similar to when we analyzed the percentage recovery of 
transiently transfected Panx1-GFP (40-50%) in BICR-M1RK cells stably 
expressing untagged Panx1 (Supplementary Figure 2), or B16-BL6 cells, 
identified for the first time to express endogenous Panx1 (Supplementary Figure 
3A and B). 
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Figure 2.4 Panx1-GFP is highly mobile at all plasma membrane locations 
Panx1-GFP was localized to three distinct plasma membrane domains of BICR-
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1Rk cells, as depicted by the schematic diagram (A).  Fluorescent images of 
Panx1-GFP were superimposed with DIC images to highlight the 
microenvironment surrounding the cell being analyzed (A-D). Selected cell 
regions where Panx1-GFP was localized at the three distinct plasma membrane 
domains were photobleached and fluorescence recovery back into the 
photobleached areas was assessed and normalized over 60s (B, C and D). 
Panx1-GFP recovery within the photo-bleached area was not significant different 
(P>0.05) amongst all three domains (E). Bars = 10 µm. n = 6-9 per plasma 
membrane domain collected from three independent experiments.  
 
 
 
 
 
 
 
 
 
 
54 
 
2.3.4 A sub-population of GFP-tagged Panx3 is evident 
at the cell surface when expressed alone or co-
expressed with Panx3 and reveals dynamic localization 
to the membrane protrusions  
We have previously reported that Panx3-GFP has a substantial trafficking defect 
causing it to be retained within the endoplasmic reticulum of NRK cells [25].  
However, when over-expressed in BICR-M1Rk cells, some evidence of Panx3-
GFP localization to the cell surface was detected (Figure 2.5A, filled arrows), 
along with the intracellular ER-like distribution of Panx3-GFP (Figure 2.5A, 
unfilled arrows). To further confirm that a sub-population of Panx3-GFP can 
traffic and localize to the cell surface, we performed biotinylation assays in live 
BICR-M1Rk cells transiently expressing Panx3-GFP. Incubation of Panx3-GFP 
expressing cells with biotin followed by pull downs with neutravidin beads 
revealed that the ~70 kD Panx3-GFP indeed traffics to the cell surface 
(Supplementary Figure 4). GAPDH was used as a negative control to confirm cell 
integrity and specificity (Supplementary Figure 4).  It was interesting to note that 
when Panx3-GFP was co-expressed with Panx3 in BICR-M1Rk cells, there was 
an apparent increase in the cell surface population of Panx3-GFP (Figure 2.5B, 
filled arrows), with some expected intracellular distribution (Figure 2.5B, unfilled 
arrows).  This data suggests that Panx3-GFP may interact with Panx3 to facilitate 
its traffic to the plasma membrane.  
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Figure 2.5 Delivery of Panx3-GFP to the cell surface  
Wild-type BICR-M1Rk cells engineered to express Panx3-GFP (A), or both Panx3 
and Panx3-GFP (B) were immunolabeled with anti-Panx3 antibody. Panx3-GFP 
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was retained mainly in an ER-like pattern (A, B, unfilled arrows) with some 
evidence of a cell surface distribution (A, B, filled arrows), while co-expression of 
Panx3 appeared to increase the cell surface population of Panx3-GFP (B). Rapid 
time-lapse imaging of live BICR-M1Rk cells co-expressing Panx3-GFP and 
Panx3 revealed that Panx3-GFP was distributed primarily in a uniform pattern 
with notable mobile fluorescent clusters at the cell surface (C, filled arrows), and 
within the cell (C, unfilled arrow). Localization of Panx3-GFP to plasma 
membrane protrusions (D, arrows) was similar to that found in cells expressing 
only Panx3 (E, arrows). Nuclei in A, B and E are stained with Hoechst 33342 
(blue). Bars= 10 µm. Representative of three independent experiments. 
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To assess the dynamic activity of Panx3-GFP at the cell surface and within 
intracellular compartments, we performed rapid time-lapse imaging on cells co-
expressing Panx3 and Panx3-GFP.  Panx3-GFP was localized at the cell surface 
in a relatively uniform pattern and as bright clusters either approaching or at the 
cell surface (Figure 2.5C, filled arrows). In addition, Panx3-GFP was also 
visualized in distinct vesicle-like structures (Figure 2.5C, unfilled arrows); and 
observed in cell surface protrusions (Figure 2.5D, arrows), that were also 
occasionally identified in cells expressing only Panx3 (Figure 2.5E, arrows).  
2.3.5 Panx3-GFP is highly dynamic at all cell surface 
domains  
We co-expressed Panx3 with Panx3-GFP and used GFP-tagged Panx3 as a 
tracer to assess and quantify the mobile fraction in various plasma membrane 
domains where: the neighboring cell surface was devoid of Panx3-GFP (Figure 
2.6A), the neighboring cell expressed Panx3-GFP (Figure 2.6B, see Movie 2.2) 
or there was no neighboring cell (Figure 2.6C). FRAP analysis of selected 
regions expressing Panx3-GFP revealed that within 60s after photobleaching, 
there was a rapid re-entry of GFP-tagged Panx3 molecules into the 
photobleached area at all micro-domains (Figure 2.6A-C, inserts), and the mobile 
fraction was calculated to be ~30-40%.  However, no significant difference was 
noticed in the total recovered fraction of Panx3-GFP within any of the plasma 
membrane domains (Figure 2.6D).  
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Figure 2.6 Panx3-GFP is highly mobile at all plasma membrane domains  
Panx3-GFP was localized to three distinct plasma membrane domains of BICR-
M1Rk cells co-expressing Panx3 (A-C). Selected cell surface regions containing 
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Panx3-GFP were photobleached and fluorescence recovery back into the 
photobleached areas was assessed and normalized over the time course of 60s. 
The percent Panx3-GFP recoverable fraction was not found to be significantly 
different amongst all three plasma membrane domains examined (P>0.05) (D). 
Bars=10µm. n=12-25 per plasma membrane domain collected from three 
independent experiments. See Movie 2.2: http://www.jbc.org/ 
Movie 2.2   The cell surface population of Panx3-GFP is highly mobile 
 FRAP and rapid time-lapse imaging was performed at cell-cell interfaces where 
both cells co-expressed Panx3-GFP and Panx3. After photobleaching, Panx3-
GFP rapidly migrated into the photo-bleached area. Intracellular vesicle-like 
structures carrying Panx3-GFP were evident as were bright fluorescent clusters 
at the cell surface. Panx3-GFP was also observed to be present in actively 
remodeling membrane protrusions. The movie represents 31 frames scanned 
every 2 seconds, with a total elapsed time of 62 seconds. 
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2.3.6 Cell surface population of Panx1-GFP and Panx3 
is insensitive to nocodazole treatment 
It has been documented that nocodazole disruption of microtubules impairs the 
continuous trafficking and regeneration of Cx43-GFP at the cell surface [88]. To 
investigate if trafficking and recovery of Panx1-GFP into the photobleached area 
is dependent on microtubules, Panx1-GFP expressing BICR-M1Rk cells were 
exposed to nocodazole for 90 minutes. Nocodazole treatment resulted in 
characteristic morphological changes in the cells from spindle-shaped to more 
cuboidal with a notable disruption of the microtubule architecture (Figure 2.7A-C). 
However, the distribution of Panx1-GFP (Figure 2.7B) and Panx3 
(Supplementary Figure 2.7.5B) at the cell surface remained relatively unaffected 
by the nocodazole treatment. Furthermore, FRAP studies revealed that Panx1-
GFP migrated into the photobleached area similarly in both untreated and 
nocodazole-treated cells (Figure 2.7C, D).  Interestingly, the inward progression 
of fluorescent recovery from the edges of the photobleached area towards the 
centre was not detected until 10 seconds post bleaching (Figure 2.7C, insert). 
Furthermore, FRAP analysis of Panx1-GFP in the presence of nocodazole 
treatment, revealed no significant difference in the recovered fraction when 
compared to the untreated cells (Figure 2.7D). Thus, nocodazole treatment does 
not visually affect the cell surface localization of Panx1-GFP, or the recovery into 
the photobleached area at the cell surface.  
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Figure 2.7 The cell surface population of Panx1-GFP is insensitive to 
nocodazole treatment 
Untreated (A) or nocodazole-treated (B) Panx1-GFP expressing BICR-M1Rk 
were immunolabeled for tubulin. As expected, nocodazole treatment collapsed 
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tubulin into paranuclear regions (A, B); however, the distribution profile of Panx1-
GFP at the cell surface and in the intracellular compartments (A, B) remained 
relatively unchanged with collapsed tubulin (B). FRAP analysis in presence of 
nocodazole revealed that Panx1-GFP was able to recover into the 
photobleached area and the percentage of recoverable fraction was not 
significantly different from the untreated cells (C and D). Bars= 10µm. n = 5-10 
per plasma membrane domains, data collected over four independent repeats.  
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2.3.7 The cell surface stability of Panx1-GFP and 
Panx3 is sensitive to cytochalasin B treatment while the 
mobility of Panx1-GFP transport vesicles is perturbed in 
the absence of intact microfilaments 
We next wanted to assess the role of actin microfilaments in stabilizing Panx1 
and Panx3 at the cell surface as well as evaluating their cell surface dynamic 
properties and transport of Panx1-GFP.  Treatment of cytochalasin B (90 min) 
caused a re-distribution of F-actin from the cell periphery (Figure 2.8A, 
Supplementary Figure 5A) to the paranuclear region (Figure 2.8B, 
Supplementary Figure 5A), with a subsequent change in cell morphology. In 
cytochalasin B treated cells, Panx1-GFP and Panx3 were mainly localized in 
intracellular compartments (Figure 2.8B, Supplementary Figure 5A, arrowheads); 
while a small population remained evident at the cell surface (Figure 2.8B, 
Supplementary Figure 5A, arrows). These findings suggest that actin may play a 
crucial role in the cell surface stability of Panx1-GFP and Panx3. FRAP analysis 
of the remaining and detectable cell surface population of Panx1-GFP after 
cytochalasin B treatment (see Movie 2.3) revealed that Panx1-GFP was mobile 
but the recovery rate was slower and the amount of the recovered fraction was 
significant less (~15-20%), when compared to the untreated cells (Figure 2.8C). 
Furthermore, rapid time-lapse imaging on the same field of cells visualized 
before (see Movie 2.4) and after (see Movie 2.5) cytochalasin B treatment 
revealed that Panx1-GFP carrying vesicles were freely able to move and travel in 
the untreated cells, however, this movement was greatly perturbed when cells 
were treated with cytochalasin B with a ~60% decrease in vesicle  
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Figure 2.8 Effect of cytochalasin B on Panx1-GFP 
Untreated (A) or cytochalasin B treated (B) Panx1-GFP expressing BICR-M1Rk 
cells were labeled with phalloidin for F-actin localization. As expected, 
cytochalasin B caused the re-distribution of F-actin from the cell surface (A) to 
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the paranuclear region (B). The collapse of F-actin microfilaments coincided with 
the intracellular accumulation of Panx1-GFP (B, arrowheads) while, a small 
population of Panx1-GFP remained evident at the cell surface (B, arrows). FRAP 
analysis in the presence of cytochalasin B treatment revealed that the cell 
surface population of Panx1-GFP was significantly impaired from entering the 
photobleached area (P<0.05) (C) N=3. Quantification of the total distance 
traveled by Panx1-GFP carrying vesicles within the same field of cells analyzed 
before and after the cytochalasin B treatment indicated a significant (P< 0.05) 
reduction in vesicle mobility in cytochalasin B treated cells (D). Bars= 10µm.  
Representative of five independent experiments.  
Movie 2.3   Panx1-GFP recovery in the photobleached area is reduced in 
response to the disruption of actin microfilaments 
Panx1-GFP expressing BICR-M1Rk cells pre-treated with cytochalasin B were 
subjected to FRAP and rapid time-lapse imaging at a cell surface where there 
was no neighboring cell (top of the frame). Recovery of Panx1-GFP into the 
photo-bleached area was minimal, becoming evident at roughly 20 seconds post 
photobleaching. The movie represents 61 frames scanned every 1 second, with 
a total elapsed time of 60seconds. See online at http://www.jbc.org/ 
Movies 2.4 and 2.5   Movement of Panx1-GFP carrying vesicles is reduced 
in response to the disruption of actin microfilaments 
Rapid time-lapse imaging was performed on the same field of BICR-M1Rk cells 
expressing Panx1-GFP before (Movie 4) and after cytochalasin B (Movie 5) 
treatment. Post 45 minutes of cytochalasin B treatment, we observed an 
apparent loss of membrane protrusions as well as a reduction in the movement 
of intracellular Panx1-GFP carrying vesicles. The movies represent 39 frames for 
untreated cells and 41 frames for cytochalasin B treated cells, scanned every 1.5 
seconds. See online at http://www.jbc.org/ 
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movement over a fixed interval of time (8.8s) (Figure 2.8D). Collectively, these 
studies suggest that microfilaments play a multifaceted role in pannexin 
stabilization at the cell surface and vesicular transport. 
2.3.8 F-actin directly binds Panx1 at the carboxy 
terminus 
To further examine the possible interaction of Panx1 with actin, lysates of wild-
type BICR-M1Rk cells engineered to express Panx1 or Panx1-GFP were 
subjected to immunoprecipitation of Panx1 prior to immunoblotting for Panx1 or 
β-actin. As expected, multiple glycosylated species of Panx1 (resolved below the 
IgG band) and Panx1-GFP were detected in the immunoprecipitates and cell 
lysates of Panx1 over-expressing cells but not wild-type BICR-M1Rk cells (Figure 
2.9A, top panel). Interestingly, β-actin was found to co-immunoprecipitate with 
Panx1 from both Panx1 and Panx1-GFP expressing BICR-M1Rk cells (Figure 
2.9A, bottom panel). To further validate the interaction of actin with Panx1, we 
conducted co-sedimentation assays where polymerized actin was mixed with 
GST fusion protein containing the carboxy terminal tail (C-tail) of Panx1. As 
observed by Sypro-stained gel, once polymerized, F-actin typically sediments in 
the pellet fraction. In the absence of polymerized actin, GST-Panx1 C-tail was 
found in both the soluble and pellet fraction (Figure 2.9B). However, when 
combined with F-actin, GST-Panx1 C-tail sediments preferentially in the pellet 
fraction (Figure 2.9B). As a control, GST alone did not sediment in the pellet 
fraction with or without F-actin (Figure 2.9B). Since the Panx1 C-tail fusion 
protein detection at ~43kD was partially masked by actin, we cleaved the C-tail of 
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Panx1 from the GST and performed a similar co-sedimentation assay. Further 
Panx1 immunoblots revealed the Panx1 C-tail at ~15kD in the pellet fraction 
(Figure 2.9C). These results suggest that F-actin binds directly to the carboxyl 
terminal of Panx1.  
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Figure 2.9 F-actin binds Panx1 at the carboxy terminus  
Wild-type (WT), or Panx1 or Panx1-GFP expressing BICR-M1Rk cells were lysed 
and subjected to immunoprecipitation (IP) for Panx1 prior to immunoblotting (IB) 
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the immunoprecipitates and cell lysates for Panx1 or  β-actin.  β-actin co-
immunoprecipitated with Panx1 and Panx1-GFP (A). Monomeric actin was 
polymerized into F-actin, incubated with either GST-fusion protein containing the 
carboxy-terminal tail of Panx1 (B) or the carboxy-terminal tail of Panx1 alone (C) 
and separated into supernatant or pellet fractions (denoted by S and P, 
respectively) prior to immunoblotting for Panx1. Panx1 was found to co-sediment 
with F-actin in the pellet fractions (B and C). Parallel gels were stained with 
Sypro gel stain and BSA and GST were used as controls in the co-sedimentation 
assays. Representative of three independent repeats. 
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 2.4 DISCUSSION 
 With the recent discovery of pannexins as a new family of channel or conduit 
forming proteins, there has been a growing interest to elucidate their biochemical 
properties, life-cycle and cellular roles.  Previous reports have linked Panx1 
channels to the release of ATP in neurons [66] and astrocytes [124], and in 
cellular response to pathological insults such as initiation of inflammatory action 
[76, 112], ischemia-induced death of neurons [78] and in tumor suppression [53]. 
Our understanding of Panx3 is even more rudimentary. While Panx3 has been 
shown to be a cell surface glycoprotein that forms conduits capable of dye 
uptake [25, 125], its cellular function remains largely unknown.  It was our 
hypothesis that being integral membrane proteins with sequence relationships to 
invertebrate innexin gap junction proteins, Panx1 and Panx3 would exhibit similar 
characteristics to the well studied Cx43 gap junction protein in terms of the 
secretory pathway governing their trafficking, dynamic properties within the 
plasma membrane and interplay with the cytoskeletal network.  
2.4.1 Trafficking of Panx1 and Panx3 to the cell surface 
It has been well established that Cx43 is co-translationally inserted into the ER 
and oligomerizes into connexons in the trans-Golgi network before trafficking to 
the plasma membrane [13]. In the case of Panx1, treatment with EndoH and 
PNGaseF enzymes have revealed that the lower molecular weight species 
constitutes the core protein that gets glycosylated to the high mannose form in 
the ER  before further glycosylation and processing in the Golgi apparatus and 
delivery to the cell surface [25, 47].   Although recent studies have extensively 
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focused on correlating glycosylation status with the delivery of Panx1 to the cell 
surface [47, 81], molecular mechanisms underlying the secretory pathway taken 
by Panx1 and Panx3 were largely unknown. To address if the transport of Panx1 
and Panx3 from the ER to the Golgi apparatus is mediated through COPII 
vesicles, we transiently co-expressed Panx1 or Panx3 with the dominant-
negative GTP-bound mutant Sar1H79F. Stabilization of Sar1 in the dominant-
negative GTP bound state has been previously shown to efficiently block COPII-
mediated ER transport of proteins to the cell surface [126]. Our data 
demonstrated that Sar1H79F expression severely inhibited the cell surface 
localization of Panx1 and Panx3, thus suggesting that COPII vesicular trafficking 
of these pannexin family members is required prior to their eventual delivery to 
the cell surface. This data also indicates that efficient GTP hydrolysis of Sar1 is 
crucial for regulating their transport from the ER compartment, as restriction of 
GTP hydrolysis of Sar1H79G to GDP has been previously shown to arrest the 
cargo-containing vesicles at the ER exit sites [122].  Consistent with our findings, 
we previously showed that Sar1 function was necessary for delivery of Cx43 to 
the cell surface [88].  Our data supports the premise that the post-ER pool of 
Panx1 and Panx3 is correlated with pannexin processing to the highly complex 
glycosylation species; whereas the accumulation of the high mannose 
intermediate species of Panx1 and Panx3 is consistent with retention of Panx1 
and Panx3 in the ER. Similar Sar1 GTPase dependency was observed for KATP 
channels, where expression of dominant-negative mutants: Sar1H79G (mutant 
incapable of hydrolysing GTP) and Sar1T39N (mutant restricted in its ability to 
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exchange GDP for GTP) prevented proper channel processing and the cell 
surface expression of the channel [127]. 
ER to Golgi transport of Panx1 and Panx3, as well as their state of glycosylation, 
was further confirmed by the use of BFA which is known to inactivate Arf1 
thereby inhibiting ER to Golgi transport [128]. Consistent with a previous study 
[81] we noticed a dramatic increase in the high mannose form of Panx1 in BFA-
treated cells. Interestingly, we also observed an accumulation of the high 
mannose species of Panx3 in response to BFA treatment, consistent with the 
inhibition of both Panx1 and Panx3 being delivered to the Golgi apparatus for 
further processing. Vesicular trafficking of Panx1 and Panx3 would also strongly 
suggest that, like Cx43, both proteins are integral transmembrane proteins that 
get transported from ER membranes in COPII vesicles.  
2.4.2 Mobility Dynamics of Panx1 and Panx3 
In our study, we used Panx1-GFP and Panx3-GFP as tracer probes to elucidate 
the distribution profile and cell surface dynamics of Panx1 and Panx3. The 
distribution of Panx1-GFP at the plasma membrane appeared to be uniform with 
occasional Panx1 enriched domains consistent with previous findings using the 
untagged Panx1 [25]. In contrast, Panx3-GFP alone revealed an increased 
intracellular profile, as reported earlier [25], with some clear evidence of its 
localization to the cell surface that was confirmed by cell surface biotinylation 
assays. Since adequate delivery of Panx3-GFP to the cell surface was required 
to investigate its dynamics at the plasma membrane, we co-expressed it with 
untagged Panx3 and found an increased cell surface expression of Panx3-GFP. 
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It is possible that Panx3 co-oligomerized with Panx3-GFP to facilitate its delivery 
to the plasma membrane; if this holds true, it would also suggest that having a 
GFP tag at the carboxy terminal tail of Panx3 does not interfere with the 
intermixing of Panx3 subunits.  A similar mechanism has been proposed for the 
cell surface rescue of a trafficking-defective, glycosylation-deficient mutant of 
Panx1 when co-expressed with either wild-type Panx1 or tetracysteine tagged 
Panx1, further indicating that tagging of pannexins does not impair its ability to 
assemble together with its untagged counterpart [81].   
In our study, delivery of both Panx1-GFP and Panx3-GFP to the cell surface 
appeared to occur at multiple plasma membrane domains via intracellular 
vesicle-like structures that formed bright clusters upon apparent fusion with the 
plasma membrane. These clusters were found to be quite mobile and displaced 
laterally within the cell surface membrane, thus supporting a model of untargeted 
delivery of Panx1 and Panx3 to all cell surface micro-domains. In contrast, Cx43-
GFP typically known to localize in punctate-like structures at the cell surface, has 
been documented to have both an arbitrary delivery to all plasma membrane 
domains [88, 96] as well as a preferred microtubule-dependent delivery to 
adherens junctions that reside in close proximity to the pre-existing gap junctions 
[129]. Interestingly, our data supports the premise that Panx1 and Panx3 are 
enriched in membrane protrusions at areas that are devoid of contacting cells, a 
situation not typically observed for Cx43 unless non-functional Cx43 mutant 
studies are performed [96]. Localization of pannexins in the finger-like membrane 
protrusions could suggest it may play a role in cell migration, as the process of 
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cell motility typically involves actin polymerization, and entails formation of fan 
like or pointed projections (lamellipodium and filopodia, respectively) at the 
leading edge [130]. Previously, the absence of Panx1 from the leading edge of a 
corneal epithelium wound in P2X7-/- mice was correlated with delayed corneal re-
epithelialization and compromised wound healing [131].  Other channel forming 
proteins such as aquaporin-1 has been implicated in increased cell migration by 
localizing to the lamellipodia [132]; whereas, migration of lymphocytes [133] and 
embryonic nerve cells [134] have been correlated with voltage-dependent K+ 
channels, thus supporting the role of channel forming proteins in regulating cell 
motility.  
Our FRAP assessments of Panx1 and Panx3 mobility identified that, similar to 
Cx43 [96], lateral movement of Panx1-GFP and Panx3-GFP occurred from the 
outer edge to the centre of the photo-bleached areas. It is notable that while the 
recovery of fluorescence into the photobleached area is likely the result of lateral 
movement of pannexins due to the time course being examined, there is also 
likely a contribution from newly delivery fluorescent protein tagged pannexins to 
the cell surface.  The relative rate of Panx1-GFP and Panx3-GFP recovery into 
the photobleached area was quite comparable in any of the examined plasma 
membrane micro domains, thus suggesting that the assembly state of these 
pannexin family members remains relatively unchanged with respect to its 
subcellular location within the plasma membrane. In our study, Panx1-GFP (and 
to a slightly lesser extent Panx3-GFP) exhibited over twice the mobility of Cx43-
GFP, which are typically arranged in gap junction-like clusters [96]. Slow 
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recovery of Cx43-GFP was also reported in HeLa cells [135].  Given the relatively 
uniform cell surface distribution of Panx1 and Panx3 that appears to be 
untargeted to specific micro-domains, we speculate that these pannexins are not 
likely packaged into dense crystalline-like structures as reported for Cx43 [39].  
Thus, the distribution and mobility of these pannexins are more in line with other 
channels and receptors such as Na+ channels [136], and acetylcholine receptors 
[137]. 
The percent of fluorescence recovery after photobleaching for both Panx1-GFP 
and Panx3-GFP (representing the mobile fraction) reached a plateau between 
40-60% with the remaining component representing the immobile fraction. 
Typically the size of the immobile fraction is dependent on the nature of the 
protein and the membrane microenvironment being assessed. For instance, the 
immobile fraction of Na+ channels ranges from ~10% in the cell body to ~40% in 
the neurite terminals [136]. Likewise, the mobile fraction of glycine receptors 
ranges from ~50% in the neuronal cell body to ~70% in the processes [138]. In 
addition, the viscosity of the membrane microdomain [139], tethering of proteins 
with scaffolds/binding partners or interaction with cytoskeleton can all contribute 
to the size of the immobile fraction [140]. 
2.4.3 Cytoskeletal dependency of Pannexin trafficking 
and mobility 
In order to assess the role of the cytoskeleton in pannexin trafficking and cell 
surface mobility dynamics, we used nocodazole and cytochalasin B to disrupt 
microtubules and microfilaments, respectively.  Nocodazole-induced disruption of 
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microtubules did not significantly alter the cell surface distribution of either Panx3 
or Panx1-GFP, which may not be totally unexpected given the predicted long 
half-life of Panx1 [25, 47]. This finding is quite distinct from Cx43, where 
enhanced growth of gap junctions [89], and Cx43 molecular movement into the 
photobleached gap junctions was minimal in nocodazole-treated cells [88] 
suggesting that Cx43 is much more dependent on microtubules than Panx1.  In 
contrast, disruption of microfilaments revealed concomitant accumulation of 
paranuclear Panx1-GFP and Panx3 with collapsed actin microfilaments, while 
only a subpopulation of Panx1-GFP or Panx3 remained at the cell surface. The 
longer turnover dynamics of pannexins, and the rapid intracellular accumulation 
upon short term cytochalasin B treatment support the premise that actin provides 
stability to the cell surface population of Panx3 and Panx1. On the other hand, 
Cx43 gap junctions have been documented to remain considerably more 
independent to the assembly state of microfilaments [141].  Mobility assessment 
of the remaining cytochalasin B-insensitive subpopulation of Panx1-GFP at the 
cell surface revealed a rather smaller mobile fraction of ~35% in the absence of 
intact microfilaments. This surprising finding was somewhat distinct from Na, K-
ATPase and reggie-1/flotillin-2 where the disruption of microfilaments caused an 
increase in the mobile fraction [142, 143]. The smaller mobile fraction of Panx1-
GFP noticed in our study may be explained by the fact that transport vesicles 
carrying Panx1-GFP either to or from the plasma membrane were less mobile 
and this decrease may mechanistically account for the reduced fluorescent 
recovery into the photobleached area.  The relative speeds of Panx1-GFP 
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carrying vesicles in untreated cells (~0.2 µm/sec) and cytochalasin B treated 
cells (~0.07 µm/sec) were also quite different.  Although credited to trafficking on 
microtubules tracks, vesicles containing Cx43-GFP showed comparable average 
speeds of ~0.5 µm/sec in untreated HeLa cells [95].  
2.4.4 Interaction of Panx1 with actin 
Given the finding that actin microfilaments regulated the distribution and cell 
surface mobility of Panx1, we speculated a direct interaction between Panx1 and 
actin may exist. Since we were best equipped to address this question for Panx1 
we first demonstrated that actin does in fact co-immunoprecipitate with Panx1. 
To further assess: 1) if Panx1 binds to monomeric or filamentous actin, 2) if 
Panx1 interaction to actin is direct, and 3) which domain of Panx1 might be 
responsible for interaction, we conducted co-sedimentation assay with a GST-
Panx1 C-tail fusion protein. Here we show that Panx1 sediments preferentially in 
the F-actin fraction, the interaction appears to be direct and it is the carboxy 
terminal tail of Panx1 that seems responsible for interacting with actin. 
Comparatively, actin binding to Cx43 is thought to be facilitated via its interaction 
with zonula occludens-1 which is a known Cx43 binding partner [144].  Future 
studies will be needed to elucidate the Panx1 motif responsible for actin binding 
at the C-terminus, and whether actin also binds to Panx3.   
 In summary, trafficking and assembly of pannexins is a precisely regulated 
process. Our study is the first to report that Panx1 and Panx3 transport is 
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dependent on Sar1-mediated COPII vesicles, cell surface Panx1 and Panx3 
have dynamic mobility properties, and Panx1 directly interacts with F-actin.  
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Supplementary Figure 2.7.1 Distribution profile of mouse Panx2 
BICR-M1Rk, HEK-293T, NRK and REK cells were transiently transfected to 
express Panx2 and Panx2-GFP alone or together. Panx2 expressing cells were 
immunolabeled for Panx2. In all the cell types, both Panx2 and Panx2-GFP were 
primarily localized to intracellular compartments. Bars = 10 µm. 
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Supplementary Figure 2.7.2 Characterization of the cell surface dynamics 
of Panx1-GFP when expressed in Panx1-expressing BICR-M1RK cells 
Panx1 over-expressing BICR-M1Rk cells engineered to co-express Panx1-GFP 
were immunoblotted (A) and immunolabeled (B) with anti-Panx1 antibody. Like 
untagged Panx1, Panx1-GFP also resolved in a multiple banding profile, where 
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β-actin was used as a protein loading control (A).  Immunolabeling of 
Panx1+Panx1-GFP cells identified the cell surface and intracellular distribution of 
GFP-tagged (B-arrowheads) and untagged (B-arrows) Panx1. Nuclei were 
stained with Hoechst 33342 (blue).  Bar = 10 µm. Three distinct plasma 
membrane domains expressing Panx1-GFP were photobleached and 
fluorescence recovery revealed no significant difference amongst them (C). n = 
8-10 per plasma membrane domain collected from three independent 
experiments.  
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Supplementary Figure 2.7.3 Characterization of the cell surface dynamics 
of Panx1-GFP when expressed in Panx1-positive BL6 cells 
BL6 cells expressing endogenous Panx1 were transiently transfected with 
Panx1-GFP and immunoblotted with anti-Panx1 antibodies (A). β-actin was used 
as a protein loading control (A). Exogenously expressed Panx1-GFP (B, 
arrowheads) and endogenously expressed Panx1 (B, arrows) exhibited a uniform 
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cell surface distribution. Nuclei were stained with Hoechst 33342 (blue).  Bar = 10 
µm. Photobleaching of Panx1-GFP at three plasma membrane domains revealed 
no significant difference in the percentage of recovery (C). n = 9-12 per plasma 
membrane domain collected from three independent experiments.  
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Supplementary Figure 2.7.4 Panx3-GFP is capable of trafficking to the cell 
surface 
Cell surface biotinylation of BICR-M1Rk cells transiently expressing Panx3-GFP 
indicated that Panx3-GFP can reach the cell surface. Cell lysates of Panx3-GFP 
with (+) or without (-) biotin were precipitated with neutravidin beads and 
immunoblotted for Panx3. GAPDH was used as a control to assess if biotin had 
entered the cell during the labeling procedure.  
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Supplementary Figure 2.7.5 The cell surface distribution of Panx3 is 
partially sensitive to cytochalasin B and insensitive to nocodazole 
treatment 
BICR-M1Rk cells transiently expressing Panx3 were treated with cytochalasin B 
(A) or nocodazole (B) and co-immunolabeled for Panx3 and tubulin or labeled for 
Panx3 together with phalloidin.  In cytochalasin B treated cells, Panx3 was 
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mainly localized to intracellular compartments (A, arrowheads), with some 
evidence of a cell surface pool (A, arrows); whereas nocodazole treatment 
caused no obvious difference in the cell surface distribution of Panx3 (B) Bar = 
10 µm.  
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CHAPTER 3: The Carboxyl Terminal Tail of Panx1 
Regulates Trafficking and Homomeric Interaction 
 
3.0 OVERVIEW 
 
This study was designed to characterize the role of the C-terminal domain of 
Panx1 in trafficking and oligomerization, by truncating the polypeptide at residue 
307 and comparing its properties to full length Panx1.  
 
 
 
 
 
 
 
 
 
_______________________ 
 
This chapter is currently in the process of being submitted for publication 
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3.1 INTRODUCTION 
Pannexins were originally discovered due to their shared sequence homology 
with the invertebrate gap junction proteins, innexins [1]. The pannexin family is 
comprised of three members: Panx1, Panx2 and Panx3 [1].  Although the scope 
of physiological significance of pannexin family members is only beginning to 
emerge, it is well established that Panx1 holds importance in: forming conduits 
for ATP release [57, 145, 146], propagation of Ca2+ waves [60], and triggering 
neuronal and immunological inflammasome [49, 77, 147].  Additionally, activation 
of Panx1 channels has been implicated in ischemic cell death [78], and seizure-
like activities [66].  In order to fulfill a wide spectrum of biological functions, a 
precise regulation of pannexin assembly and trafficking is required.  
In general, glycosylation of integral membrane channel proteins can have 
important implications on proper folding and subunit assembly, cell surface 
expression, and function [148-150]. We and others have shown that Panx1 is N-
linked glycosylated [25, 47] and exists as core (Gly0), high mannose (Gly1) and 
complex (Gly2) species [59].  The significance of Panx1 glycosylation on 
trafficking was first explored using site-directed mutagenesis of putative N-linked 
glycosylation sites [47]. While the Panx1N204Q mutant was fully glycosylated and 
expressed all the three forms: Gly0, Gly1 and Gly2, the Panx1N254Q mutant was 
not glycosylated and was expressed only as a Gly0 species [25, 47]. Moreover, 
the Panx1N254Q mutant displayed trafficking defects suggesting that glycosylation 
played a role in proper trafficking of Panx1 to the cell surface.    
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Cell surface Panx1 exists in the form of hexamer channels, termed pannexons 
[47]. In MDCK cells, Panx1 has been shown to rescue the delivery of the 
Panx1N254Q mutant to the cell surface suggesting that  they co-oligomerize [81].  
Thus, the lack of glycosylation does not perturb the ability of Panx1N254Q subunits 
to fold properly and intermix with Panx1. Interestingly, despite the glycosylation 
deficiency and the low levels of the Panx1N254Q mutant at the cell surface, the 
mutant is still capable of forming functional single membrane channels that can 
take up dye [25].  A glycosylation deficient mutant of zebrafish Panx1 (zfPanx1-
N246K), on the other hand, traffics to the cell surface, but displays impaired 
uptake of ethidium bromide compared to WT zfPanx1 [151].  
The function of Panx1 channels has also been investigated by engineering 
specific point mutations in the polypeptide sequence and expressing these 
mutants in reference cell models. First, substitution of lysinealanine at residues 
248 and 265 in the second extracellular loop resulted in a loss of Panx1 channel 
function.  Mutation of arginine at position 75 (in the first extracellular loop) to 
alanine, lysine, glutamine, or cysteine was further used to assess the inhibitory 
effects of ATP analogues on Panx1 channel currents [63].  Based on the single 
mutation analysis of these mutants, R75 was identified as a key ATP binding site 
for regulation of Panx1 channel activity [63]. When expressed in Xenopus 
oocytes, the C346S mutant formed constitutively leaky channels thereby causing 
cell death; whereas C136S or C436S mutants did not significantly alter Panx1 
channel properties [152].  Although the C346S mutant was only partially 
glycosylated to the Gly1 form, as opposed to the full glycosylation states 
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achieved by the C136S and C426S mutants, all three mutants trafficked and 
localized to the cell surface [152]. Thus, these results suggest that partial 
glycosylation of Panx1 to the high mannose species (Gly1) is sufficient to drive a 
subpopulation to the cell surface, a notion further supported by our recent work 
demonstrating cell surface biotinylation of the Gly1 species of Panx1N254Q [59]. 
Clearly, engineering of mutations along several domains of Panx1 provide 
insights into Panx1 assembly, trafficking and channel function. While several 
studies have investigated at the effect of single amino acid substitutions within 
specific Panx1 motifs, mutants where entire Panx1 domains have been deleted 
have not be studied. We were particularly interested in the large 127 amino acid 
long C-terminal domain as this cytoplasmic domain is a prime candidate exposed 
for interacting with other regulatory proteins. In fact, we have previously shown 
that the Panx1 C-tail acts as a substrate for binding actin, which provides a 
multifaceted role in vesicular transport, cell surface mobility, and stability of 
Panx1 [153].  In the present study we expand our understanding of the role of the 
Panx1 C-terminus by investigating the trafficking and oligomeric potential of C-
terminal truncated Panx1. 
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3.2 EXPERIMENTAL PROCEDURES 
3.2.1 Cell culture and reagents 
BICR-M1Rk cells and  human embryonic kidney (HEK)-293T, cells were cultured 
in high glucose DMEM (Invitrogen, Burlington, ON, Canada), supplemented with 
10% fetal bovine serum, 100 units/ml penicillin, 100 µg/ml streptomycin, and 2 
mM L-glutamine (all from Invitrogen, Burlington, ON, Canada).  
3.2.2 Expression constructs and transfection 
To truncate Panx1 carboxy tail at amino acid position 307, primers were 
designed with flanking sites for HindIII digestion- using the forward primer: 5’- 
GATAAGCTTACCATGGCCATCGCCCAC, and NotI digestion for reverse primer: 
5’- TCAAGCGGCCGCACCACTTTGAGAATG. PCR products were digested with 
HindIII and NotI restriction enzymes, and inserted into the pcDNA3-mRFP vector 
(Addgene Plasmid Repository). Truncated Panx1 and RFP (denoted as 
Panx1T307-RFP) were separated by a five-amino acid polylinker encoded by the 
nucleotide sequence (GGACCGGTCGCCACC). The resulting construct was 
validated by sequencing. 
To create the Panx1-RFP construct, full length Panx1 (encoding 426 amino 
acids) was excised from a previously engineered pEGFP-N1 vector [25] using 
HindIII and BamHI restriction enzymes. Panx1 was fused with RFP in frame to 
the carboxyl terminus in the pcDNA3-mRFP vector by a thirty one amino acid 
polylinker encoding by the nucleotide sequence:  
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(CTGTCGACGGTACCGCGGGCCCGGGATCCACTAGTAACGGCCGCCAGTG
TGCTGGAATTCTGCAGATATCCATCACACTGGCGGCCGCTCGAG).  
For transfection of Panx1T307-RFP and Panx1-RFP, cells were grown overnight to 
50-70% confluency in 35 mm dishes and transfected in Opti-MEM1 (Invitrogen) 
media containing 2 μL of Lipofectamine 2000 (Invitrogen) and 5 µg of plasmid 
DNA. For co-expression studies, HEK-293T cells were plated in 100 mm dishes 
and 7-9 µg of Panx1 was co-transfected with 10-15 µg of either Panx1T307-RFP 
or Panx1-RFP in Opti-MEM1 media containing 15 μL of Lipofectamine2000.  
Opti-MEM1 media was replaced with complete culture media 4 hours after 
transfection at 37˚C. 
3.2.3 Immunocytochemistry 
Cells were immunolabeled as previously described [153].  Briefly, cells grown on 
a glass coverslips were fixed using ice-cold 80% methanol and 20% acetone for 
20 minutes at 4˚ C and blocked in 2% blocking solution (Bovine Serum Albumin -
(BSA; Sigma)) for 30 minutes. Cells were incubated for 1 hour at room 
temperature with affinity-purified polyclonal Panx1 antibody at a concentration of 
2 μg/mL, a 100 fold dilution of monoclonal anti-GM130 antibody (BD 
Transduction Laboratories), a 500 dilution of monoclonal anti-PDI antibody 
(Stressgen) or a 200 fold dilution of polyclonal anti-RFP antibody (Abcam). Cells 
were incubated with goat anti-rabbit or goat anti-mouse Alexa Fluor488 (1:500, 
Invitrogen) for 45 minutes at room temperature. Cells were rinsed with PBS and 
nuclei were stained with Hoechst 33342 and mounted. Immunolabeled cells were 
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imaged using a 63x oil objective lens mounted on a Zeiss LSM 510 META (Zeiss, 
Toronto, ON) system.  
3.2.4 Co-Immunoprecipitation and immunoblotting 
Protein lysates were collected from cells expressing Panx1T307-RFP and Panx1-
RFP with or without Panx1 using a lysis buffer as previously described [153]. 
Protein concentrations were measured using a BCA protein determination kit 
(Pierce). The co-immunoprecipitation assay was performed mainly as previously 
described [154]; briefly, 1 mg of each protein lysate was incubated with 10 μg/ml 
of anti-Panx1 CT-395 antibody and rocked overnight at 4°C. The following day, 
30 μl (50% slurry) of protein A-Sepharose beads were added to the lysates and 
incubated for an additional 2 hours at 4°C. Thereafter, beads were collected by 
centrifugation at 4500 rpm for 2 minutes, washed three times to remove any 
nonspecific binding, and boiled for 5 minutes in 2x Laemmli buffer prior to 
resolving on 8-10% SDS-PAGE gels.  
For cellular lysates control, a total of 30-40 µg of protein was used, and gels were 
transferred to a nitrocellulose membrane using the iBlot Dry Blotting system 
(Invitrogen). Nitrocellulose membranes were blocked in 3% BSA or 5% blotto 
milk (Santa Cruz Biotechonologies), and probed overnight with polyclonal affinity 
purified anti-Panx1 (0.2 µg/mL) or polyclonal anti-RFP (1:2,000) antibodies at 
4˚C. Monoclonal anti-GAPDH antibody (1:10,000, Millipore) was used to assess 
protein loading. Since both the RFP and Panx1 antibodies were raised in rabbits, 
detection of co-immunoprecipitates was achieved using the Clean-Blot IP 
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Detection Reagent (horse radish peroxidase; Pierce Chemical) as a secondary 
antibody at 1:4,000 dilution for 45 minutes, in order to minimize the appearance 
of the IgG bands.  Blots were incubated in reagents from SuperSignal West 
Femto chemiluminescent kit (Pierce Chemical) prior to scanning with the BioRad 
system. For cell lysates, detection of primary antibody binding was performed 
using mouse IgG IR dye 800 at 1:10,000 (Rockland Immunochemicals) or rabbit 
IgGAlexa 680 at 1:10,000 (Invitrogen) and scanning with the Odyssey infrared 
imaging system (Licor). 
3.2.5 Deglycosylation assays 
Enzymatic digestion of glycan chains using peptide N-glycosidase (PNGase) F 
and endo-β-N-acetylglucosaminidase (Endo) H were performed as previously 
described [59]. Briefly, 35 μg of HEK-293T cell lysates containing either 
Panx1T307-RFP or Panx1-RFP were incubated in the presence or absence of 10U 
of N-glycosidase F and incubated for 1 hour at 37°C prior to immunoblotting 
using the RFP antibody. Similarly, for Endo H treatment,  35 μg of protein was 
incubated with or without 5000U of the enzyme for 1 hour at 37°C and samples 
were resolved on a 8% SDS PAGE before transferring to nitrocellulose 
membranes and probing with an anti-RFP antibody. 
3.2.6 Cell surface biotinylation 
HEK-293T cells ectopically expressing either Panx1T307-RFP or Panx1-RFP were 
subjected to biotinylation 48 hours following transfection. To prevent any 
potential internalization of cell surface proteins, all reagents and cell cultures 
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were maintained on ice. Cell culture dishes were first rinsed three times with cold 
PBS to remove media and incubated thereafter either in PBS alone or in PBS 
containing 1 mg/ml of EZ-link Sulfo NHS-LC biotin (Pierce Chemical) for 20 
minutes at 4°C.To quench any excess biotin, cell culture dishes were first rinsed 
and then incubated in PBS containing 100 mM glycine for an additional 15 
minutes at 4°C. Proteins were then extracted from both unlabeled and biotin 
labeled dishes using the SDS lysis buffer (1% Triton X-100 and 0.1% SDS in 
PBS), and quantified using a BCA protein determination kit (Pierce). 1 mg of cell 
lysates from biotin labeled and unlabeled samples were incubated with 50 μl of 
NeutrAvidin-agarose beads (Pierce Chemical) overnight at 4°C. The following 
day, beads were washed with IP lysis buffer (150 mM NaCl, 10 mM Tris-HCl, pH 
7.4, 1 mM EDTA, 0.5% NP-40, and 1% Triton X-100) containing 1 mM NaF and 1 
mM Na3VO4, and suspended in 2x Laemmli buffer before boiling for 5 minutes 
and resolving on the SDS-PAGE. Total protein containing 30-40 μg of lysate was 
simultaneously resolved on the gel, transferred to nitrocellulose and probed for 
RFP and Panx1 expression.  
3.2.7 Pharmacological inhibitors 
HEK-293T cells expressing Panx1T307-RFP and Panx1 together or individually 
were exposed to 10 µM of lactacystin (Sigma) and 200 µM of chloroquine 
(Sigma) for 20 hours prior to protein extraction. Total protein lysates of treated 
and untreated cells were then subjected to immunoblotting for RFP and Panx1. 
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3.3 RESULTS 
In order to characterize the biological significance of the Panx1 C-tail, we 
truncated Panx1 at residue 307 that is approximately 10 amino acids 
downstream of where the fourth transmembrane domain is predicted to exit the 
plasma membrane. To facilitate detection of the Panx1 truncated mutant, the 
mutant was tagged with red fluorescent protein (RFP). To control for any possible 
adverse effect of the RFP tag, we also tagged full length Panx1 with RFP to be 
used in comparative studies.  
3.3.1 RFP tagging does not modify the distribution 
profile of Panx1 
RFP is a fluorescent protein derived from Discosoma coral that is spectrally 
distinct from the green fluorescent protein (GFP), originally cloned from 
Aequorea jellyfish [155].  In order to validate that the RFP tag does not modify 
the trafficking of Panx1, we compared it to the GFP-tagged version that 
previously showed similar cell surface delivery and localization patterns to 
untagged Panx1. Transfection of Panx1-RFP in BICR-M1Rk cells stably 
expressing Panx1-GFP revealed relatively uniform co-localization at the cell 
surface and overlap in vesicle-like compartments distributed intracellularly 
(Figure 3.1A, arrowheads). Interestingly, similar to Panx1-GFP, RFP-tagged 
Panx1 was also found in plasma membrane protrusions (Figure 3.1B, arrows).  
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Figure 3.1 Panx1-RFP co-localize with Panx1-GFP  
Over-expression of Panx1-RFP (red) in BICR-M1Rk cells stably expressing 
Panx1-GFP (green) resulted in their co-localization (yellow) in a relatively uniform 
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pattern at the cell surface and in vesicle-like structures (A, arrowheads). Panx1-
RFP also co-localized (yellow) with Panx1-GFP at the plasma membrane 
protrusions (B, arrows). Nuclei were counterstained with Hoechst.  Bar = 10 µm. 
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This suggests that like GFP, RFP tagging of the Panx1 carboxyl terminal tail also 
displays distribution characteristics similar to the untagged counterpart and 
therefore could be employed as a control to study the biological properties of 
Panx1T307-RFP.  
3.3.2 The C-tail of Panx1 is important for trafficking to 
the plasma membrane 
Both Panx1T307-RFP and Panx1-RFP were over-expressed in either BICR-M1Rk 
or HEK-293T cells, as these cell lines are devoid of endogenous Panx1 [59, 153]. 
The high transfection efficiency of HEK-293T cells was deemed ideal for 
immunoblotting experiments; however, given their small spindle morphology, 
large nuclei and low cytoplasmic volume [59], they were not as suitable for 
immunolocalization studies as the larger BICR-M1Rk cells.  
When Panx1T307-RFP was expressed in BICR-M1Rk cells the mutant was found 
to primarily reside in intracellular compartments (Figure 3.2A). In contrast, full 
length Panx1-RFP was capable of trafficking and localizing to the cell surface in 
a relatively uniform manner (Figure 3.2B). As expected, the Panx1 CT-395 (from 
here on denoted as the anti-Panx1) antibody detected the full length Panx1-RFP 
but was unable to detect Panx1T307-RFP due to the deletion of the antigenic 
epitope used to generate the antibody (Figure 3.2A and B).  In comparison, the 
RFP antibody detected both Panx1T307-RFP and Panx1-RFP (Figure 3.2C and 
D).  Interestingly, the subcellular distribution profile of both Panx1T307-RFP and 
Panx1-RFP was consistent between BICR-M1Rk and HEK-293T cells (Figure 
3.2E and F), eliminating any potential cell type differences.  
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Figure 3.2 The C-tail of Panx1 is critical for trafficking to the cell surface 
Panx1T307-RFP was localized to the intracellular compartments (A, red) while 
Panx1-RFP was found at the cell surface (B, red) in BICR-M1Rk cells.  
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Immunolabeling with Panx1 detected Panx1-RFP and not Panx1T307-RFP (A and 
B, green). As expected, the anti-RFP antibody localized both Panx1-RFP and 
Panx1T307-RFP (C and D, green). The subcellular distribution of full length and C-
tail truncated Panx1 remained consistent in HEK-293T cells (E and F, red). 
Nuclei were counterstained with Hoechst.  Bar=10µm. 
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Collectively, these findings suggest that the C-terminal of Panx1 is critical for 
delivery and retention of Panx1 at the cell surface.  
3.3.3 Panx1T307-RFP is primarily retained within the ER 
compartment and glycosylated to a high mannose form 
In order to identify the subcellular localization of Panx1T307-RFP, cells were 
immunolabled for ER (PDI and calnexin) and Golgi (GM130) resident proteins. 
Although the distribution patterns of both Panx1T307-RFP and PDI (an ER lumen 
protein) partially overlap, their localization patterns were not identical (Figure 
3.3A). In contrast, the ER integral membrane protein marker, calnexin, revealed 
strong co-localization with Panx1T307-RFP, particularly around the perinuclear 
region (Figure 3.3B).  Not surprisingly, Panx1-RFP at the cell surface did not 
localize with either PDI or calnexin (Figure 3.3A and B). Additionally, labeling with 
the cis-Golgi matrix protein, GM130, revealed a distinct distribution profile from 
both Panx1T307-RFP and Panx1-RFP (Figure 3.3C). Thus, in the absence of the 
C-tail it appears that Panx1 is largely retained in the ER compartment. As a 
glycoprotein, it is well documented that Panx1 exhibits multiple banding patterns 
reflecting the core unglycosylated protein: Gly0; a high mannose glycosylated 
species associated within the ER: Gly1; and the extensively glycosylated species 
that is modified in the Golgi apparatus prior to cell surface delivery: Gly2 [25, 47, 
59]. To address if Panx1T307-RFP also resolves as multiple species, lysates of 
HEK-293T wild-type cells, cells over-expressing full length Panx1 fusion proteins, 
and the C-tail truncated protein were subjected to immunoblotting using anti- 
RFP and Panx1 antibodies. 
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Figure 3.3 Characterization of the subcellular distribution of Panx1T307-RFP  
BICR-M1Rk cells ectopically expressing Panx1T307-RFP (red) or Panx1-RFP (red) 
were immunolabeled with antibodies against PDI, calnexin and GM130. 
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Panx1T307-RFP expressing cells revealed an intracellular pattern that exhibited 
partial colocalization with resident proteins of the endoplasmic reticulum. The 
bulk of Panx1-RFP trafficked to the cell surface with no obvious co-localization 
with PDI (A, merge) or calnexin (B, merge). GM130 (green) was mainly localized 
around the perinuclear region.  Nuclei were counterstained with Hoechst.   
Bar=10µm. 
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Owing to the fusion of RFP (~27-30kD), C-tail truncated Panx1 was detected as 
a doublet at a molecular weight of ~50kD, whereas full length Panx1 resolved as 
multiple bands at ~75-80kD (Figure 3.4A). Consistent with our immunolabeling 
data, the Panx1 CT-395 antibody did not detect Panx1T307-RFP, but identified full 
length GFP and RFP -tagged Panx1 (~75-80KD), as well as occasionally some 
bands near 50kD, which are likely proteolytic products (Figure 3.4B). As 
expected, WT cells did not express any Panx1, however, some non-specific 
bands were observed above 50 kDa when probed with the RFP antibody (Figure 
3.4A).  
In order to determine whether the banding pattern of Panx1T307-RFP was a result 
of glycosylation, we enzymatically digested the cell lysates using N-glycosidase F 
prior to immunoblotting.  Within an hour, N glycosidase F treatment of Panx1-
RFP removed glycan chains associated with the Gly1 and Gly2 species and 
shifted the banding pattern to the level of Gly0 (Figure 3.4C). Similarly, the upper 
band of Panx1T307-RFP, likely the Gly1 species, also shifted to the lower band 
(Gly0) upon N-glycosidase F digestion (Figure 3.4D). To further assess the 
extent of glycosylation, both Panx1T307-RFP and Panx1-RFP were subject to 
Endo H digestion, which selectively cleaves the high mannose form of a 
glycoprotein.  Consistent with previously reported digestion of mouse [47, 59] 
and rat untagged Panx1 [47], Endo H treatment of Panx1-RFP revealed a shift in 
only the intermediate Gly1 band without reducing the Gly2 species (Figure 3.4E). 
Interestingly, the upper band of Panx1T307-RFP was also sensitive to the Endo H 
treatment (Figure 3.4F).  
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Figure 3.4 Panx1T307-RFP exhibits glycosylation states distinct from Panx1-
RFP 
Protein lysates of HEK-293T WT cells and cells over-expressing Panx1-GFP, 
Panx1-RFP and Panx1T307-RFP were immunoblotted for RFP tagged Panx1 (A 
and B). Panx1-RFP (A and B) resolved similar to Panx1-GFP (B) in a multiple 
banding profile, whereas Panx1T307-RFP was detected primarily as a doublet 
~50kD (A). Digestion of Panx1-RFP and Panx1T307-RFP with N-glycosidase F (C 
and D) and Endo H (E and F) revealed that while Panx1-RFP can exist as a core 
(Gly0), high mannose (Gly1) and complex glycoprotein species (Gly2), 
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Panx1T307-RFP primarily consists of core (Gly0) and   high mannose (Gly1) 
species.  GAPDH was used as a protein loading control.  
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Taken together, these results suggest that in the absence of the C-tail, 
glycosylation of Panx1 is limited to a high mannose form. 
3.3.4 Panx1 is incapable of rescuing Panx1T307-RFP to 
the plasma membrane 
Panx1 is reported to presumably oligomerize with the glycosylation-deficient 
mutant, Panx1N254Q, to rescue its predominant intracellular distribution to the cell 
surface [81]. To examine whether the C-tail of Panx1 regulates homomeric 
interactions, we transiently co-expressed Panx1 with Panx1T307-RFP. When 
Panx1 is ectopically expressed alone or in conjunction with Panx1-RFP, a 
relatively uniform cell surface distribution is revealed (Figure 3.5A and B). In 
contrast, the intracellular retained Panx1T307-RFP was not rescued to the cell 
surface when co-expressed with Panx1; instead, a sub-population of Panx1 was 
detected intracellularly in the perinuclear region (Figure 3.5C). Thus, suggesting 
that intermixing of Panx1 with the C-tail mutant does not result in rescue of the 
mutant to the cell surface. 
3.3.5 C-Tail of Panx1 is involved in glycosylation-
dependent homomeric interactions  
To further examine the potential role of the Panx1 C-tail in Panx1 
oligomerization, lysates of HEK-293T cells, cell over-expressing Panx1 alone or 
in combination with either Panx1-RFP or Panx1T307-RFP were subjected to 
immunoprecipitation for Panx1.   
 
111 
 
 
Figure 3.5 Panx1 expression did not relocalize Panx1T307 to the cell surface    
HEK-293T cells transfected with Panx1 alone (A), or with Panx1-RFP (B, red) 
and Panx1T307-RFP (C, red) were immunolabeled for Panx1 (green). When 
expressed alone (A) or with Panx1-RFP (B), Panx1 reached the cell surface and 
also colocalized with Panx1-RFP (B, merge). The intracellular localization pattern 
of Panx1T307-RFP (red) was evident in the presence of Panx1 (green) (C).  Nuclei 
were counterstained with Hoechst.  Bar=10µm. 
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When immunoblotted with either RFP or Panx1 antibodies, immunoprecipitates 
of Panx1 co-expressed with Panx1-RFP revealed both the high mannose (Gly1) 
and complex glycosylated species (Gly2), with much lower detection of the core 
(Gly0) species (Figure 3.6A and B).  In contrast, only trace amounts of the Gly1 
species of Panx1T307-RFP was found to co-immunoprecipitate with Panx1 (Figure 
3.6A). Conversely, immunoblotting with the anti-Panx1 antibody revealed the 
Gly1 and Gly0 species with little evidence of the Panx1 Gly2 species when co-
expressed with Panx1T307-RFP (Figure 3.6B).  Interestingly, total cell lysates also 
revealed little Gly2 species of Panx1 in the presence of Panx1T307-RFP (Figure 
3.6B). Collectively, these findings suggest that all three species of Panx1 can 
readily interact with Panx1-RFP.  In contrast, when the C-tail of Panx1 is 
truncated, only a weak interaction exists with Panx1, with a preference for the 
core and high mannose species. 
3.3.6 Panx1T307-RFP has a dominant-negative effect on 
the maturation of Panx1 to the Gly2 Species 
To determine the effect of Panx1T307-RFP mutant on the maturation of Panx1 to 
the Gly2 species and delivery to the cell surface we conducted a cell surface 
biotinylation assay on live HEK-293T cells expressing Panx1T307-RFP, and 
Panx1-RFP alone or in combination with Panx1.  As depicted by Panx1 
immunoblotting of NeutrAvidin pulled down fractions and cell lysates, all species 
of Panx1-RFP were capable of trafficking to the cell surface, with a preference for 
the Gly2 species when probed with anti-RFP antibody (Figure 3.7A).  
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Figure 3.6 Truncation of the Panx1 C-tail limits the interaction with the full 
length Panx1  
Immunoprecipitation of Panx1 was performed on cell lysates from WT HEK-293T 
cells and cells ectopically expressing either Panx1 alone or with Panx1-RFP and 
Panx1T307-RFP.  A robust interaction of the Gly1 and Gly2 species of Panx1-RFP 
with Panx1 was revealed when immunoblotted for RFP (A) and Panx1 (B). 
Panx1T307-RFP also co-immunoprecipitated with Panx1, however, it was mainly 
the Gly1 species that was weakly pulled down (A). Co-immunoprecipitaton of 
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Panx1 with Panx1T307-RFP revealed reduced interaction with the Gly2 species of 
Panx1 (B). Expression levels of all Panx1 variants were also assessed by 
probing the total protein lysate with RFP or Panx1 antibody.  
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In contrast, despite detectable Panx1T307-RFP expression in the cell lysates, 
NeutrAvidin fractions contained virtually no Panx1T307-RFP (Figure 3.7A). 
As a control, the lack of immunolabeling of GAPDH suggests that biotin did not 
penetrate into the cell.  When co-expressed with Panx1, a subpopulation of the 
highly glycosylated species of Panx1-RFP (Figure 3.7B and C), as well as all the 
three glycosylation forms of Panx1, reached the cell surface (Figure 3.7C). 
However, when co-expressed with Panx1T307-RFP, there was a noticeable 
reduction in the cell surface population of all the three species of Panx1 (Figure 
3.7C), with no clear evidence of plasma membrane expression of Panx1T307-
RFP, even in the presence of Panx1 (Figure 3.7B). These findings support the 
notion that the Panx1T307-RFP mutant is acting dominantly to reduce the delivery 
of Panx1 to the cell surface.  
3.3.7 Panx1T307-RFP is preferentially degraded through 
the proteasomal pathway 
Given the predominant intracellular distribution of Panx1T307-RFP, we assessed 
whether Panx1T307-RFP is targeted to proteasomal or lysosomal degradation 
using the pharmacological inhibitors lactacystin and chloroquine, respectively. 
Blocking the proteasomal pathway with lactacystin clearly showed a robust 
accumulation of both the Gly1 and Gly0 species of Panx1T307-RFP, with no 
detectable change in protein expression upon chloroquine exposure (Figure 
3.8A). On the contrary, inhibition of the lysosomal and not the proteasomal 
pathway revealed a pronounced increase in the Gly1 and Gly2 species of both 
Panx1-RFP (Figure 3.8A) and Panx1 (Figure 3.8B). In comparison to Panx1 
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alone (Figure 3.8B), co-expression with Panx1T307-RFP showed an overall 
decrease in the Gly2 species of Panx1, with a noticeable reduction in the Gly1 
species, upon chloroquine treatment (Figure 3.8C). When compared to 
Panx1T307-RFP alone (Figure 3.8A), co-expression with Panx1 revealed an 
accumulation of the Gly1 species of Panx1T307-RFP with the chloroquine 
treatment, without considerably altering the expression upon lactacystin 
treatment (Figure 3.8C).  
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Figure 3.7 Panx1T307-RFP reduces the cell surface expression of Panx1  
Protein lysates of HEK-293T cells labeled with (+) or without (-) biotin were 
precipitated with NeutrAvidin beads prior to immunoblotting for RFP and Panx1. 
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Cell surface biotinylation of Panx1-RFP revealed that all glycosylated species of 
Panx1 trafficked to the cell surface, while no clear cell surface expression of 
Panx1T307-RFP was detected (A). NeutrAvidin fraction displayed a pronounced 
cell surface expression of both Panx1-RFP and Panx1, when co-expressed 
together (C). Plasma membrane biotinylation of co-expressed Panx1 could not 
detect Panx1T307-RFP at the cell surface (B); however Panx1T307-RFP expression 
reduced the overall expression of Panx1 (C). Total protein lysates labeled with 
(+) or without (-) biotin were also assessed for expression levels of Panx1, 
Panx1-RFP and Panx1T307-RFP. GAPDH (an intracellular protein) was used to 
detect any internalization of biotin.  
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Figure 3.8 Panx1 is destined for proteasomal-mediated degradation in the 
absence of the C-tail 
Panx1T307-RFP, Panx1-RFP and Panx1 expressing HEK-293T cells were 
exposed to either proteasomal (lactacystin) or lysosomal (chloroquine) inhibitors 
for 20 hours prior to immunoblotting for RFP and Panx1.  Expression of both the 
Gly0 and Gly1 species of Panx1T307-RFP increased with lactacystin exposure, 
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with no detectable change upon chloroquine treatment (A). Lactacystin-treated 
cells expressing Panx1-RFP (A) or Panx1 (B), revealed a slight reduction in the 
expression of the Gly2 species; while chloroquine treatment resulted in the 
accumulation of the Gly1 and Gly2 species. Co-expression of Panx1 with 
Panx1T307-RFP clearly reduced the Gly2 form of Panx1 (C). When co-expressed 
together, chloroquine treatment caused a reduction in the Gly1 form of Panx1, 
while Gly1 increased in cells expressing Panx1T307-RFP (C).  GAPDH was used 
as a protein loading control. 
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3.4 DISCUSSION 
To identify the role of the Panx1 C-terminal domain in regulating Panx1 
trafficking, glycosylation, oligomerization and degradation, the current study 
employed a Panx1 mutant that lacked the last 119 amino acid residues from the 
C-terminus.  First we identified that in the absence of the C-terminal tail the 
mutant failed to traffic to and be retained at the cell surface. Second, the Panx1 
truncated mutant was retained primarily within the ER where it was found as a 
core Gly0 protein or a high-mannose Gly1 species. Third, the Panx1 mutant 
failed to substantially interact with Panx1 suggesting that the C-terminal domain 
plays a role in Panx1 homomeric oligomerization. Finally, the ER-retained 
truncated mutant was subjected to proteasomal degradation, which is consistent 
with ER associated degradation. 
3.4.1 Cell surface trafficking, post-translation 
modification and homomeric interaction of Panx1T307-
RFP  
It has been well established that Panx1 traffics to the plasma membrane and 
distributes itself in a fairly uniform pattern, with some evidence of cell surface 
clustering [153]. Our results revealed that the deletion of the C-tail causes a shift 
in Panx1 localization, with a predominant retention in the ER. Similarly, truncation 
of the C-tail domain has been shown to perturb the cell surface trafficking of 
several other integral membrane proteins such as the human anion exchanger 
AE1 [156],  the human sodium dependent vitamin C transporter 1 [157], the A1 
adenosine G-protein coupled receptor [158] and Glut 1 and Glut 4 isoforms of 
glucose transporter [159], thus suggesting that an intact C-tail domain is required 
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to facilitate the adequate delivery of several proteins to plasma membrane.  In 
addition, the cell surface trafficking of Panx1 is partially dependent on 
addition/processing of the glycan chains in the ER-Golgi compartments [47, 59]. 
Therefore, to determine if the lack of the cell surface localization of Panx1T307-
RFP was related to its glycosylation status we further assessed this possibility. 
Our results indicated that Panx1T307-RFP exists as both core (Gly0) and high 
mannose (Gly1) species. Given that Panx1 is glycosylated on the second 
extracellular loop [25, 47], together with the fact that the Gly1 species of 
Panx1T307-RFP was sensitive to Endo H treatment, our data suggests that 
deletion of the C-tail does not interfere with normal ER-based glycosylation 
events. It is quite likely that the trafficking defect is thus independent of ER-based 
glycosylation events but could still be related to proper Panx1 folding or 
oligomerization. This notion is somewhat similar to a case involving C-tail 
mutants of A1 adenosine G-protein coupled receptors, where incomplete 
modifications of the complex carbohydrate chains was correlated with defects in 
exiting the ER compartments of HEK-293 cells [158].  In addition, the ER 
retention of the C-tail truncated mutants of A1 receptors was also associated with 
incomplete folding and failed ER quality control [158]. It is well established that 
ER based chaperones, such as calnexin, mediate quality control by aiding in 
proper folding of glycoproteins, while restricting the trafficking of misfolded 
proteins [160]. In our studies, the strong co-localization of Panx1T307-RFP and not 
Panx1-RFP with calnexin could possibly reflect the misfolded state of Panx1 in 
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the absence of its C-tail. Alternatively, failure of truncated Panx1 acquiring a 
proper oligomeric state could also be the cause for its ER retention [161, 162]. 
Misfolded mutant proteins often impair cell surface trafficking of their wild-type 
counterparts. One of the well characterized examples of this phenomenon is the 
ER retention of the Cl- ion channel cystic fibrosis transmembrane conductance 
regulator (CFTR) in the presence of its mutant counterpart ∆F508 [163]. Our cell 
surface biotinylation assay of cells co-expressing Panx1 and the truncated 
mutant did not reveal the mutant at the cell surface; however, the presence of the 
mutant clearly reduced the cell surface expression of all the Panx1 species. 
Interestingly, a similar ER variant-induced inhibition of the cell surface delivery of 
WT members of Wnt receptors was deemed to be due to impaired 
oligomerization [164]. Given that Panx1 oligomerizes as a hexamer prior to 
trafficking to the cell surface [47], we were interested in investigating if the partial 
retention of Panx1 in the presence of the mutant was due to potential co-
interactions between the mutant and Panx1, while being residents of the ER.  
Interestingly, only a weak interaction between the Gly1 species of Panx1T307-RFP 
and full length Panx1 was detected, thus suggesting the importance of the intact 
C-tail in mediating efficient oligomerization process of Panx1.   
3.4.2 Fate of the C-tail truncated mutant of Panx1 
It is widely accepted that misfolded or improperly assembled proteins retained in 
the ER are destined for premature degradation, if molecular chaperones are 
unable to correct their folding [159]. A proteasomal based degradation pathway is 
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linked to the degradation of incorrectly folded glycoproteins that are rejected by 
the quality control system of the ER [165], a process termed ER-associated 
degradation (ERAD).  Proteasomal inhibition-induced accumulation of Panx1 in 
our studies, together with its localization in the calnexin-positive ER 
compartments suggests that this mutant is likely a substrate for ERAD. 
Interestingly and consistent with a study by Boassa et al., [47], our studies 
suggest that full length Panx1 is destined for lysosomal degradation.  In 
particular, chloroquine-induced lysosomal inhibition of Panx1 revealed an 
increase in the more complex-mature form and the high mannose glycosylated 
species of Panx1. Since both glycosylated species of Panx1 (complex and high 
mannose) are capable of trafficking and residing at plasma membrane [59], its 
accumulation suggests that Panx1 cycling through the cell surface are destined 
for lysosomes for degradation. Alternatively, since a subpopulation of the high 
mannose species of Panx1 is also associated with the ER pool [47], its 
accumulation could either be a consequence of a negative-feedback mechanism, 
generated from the cell surface pool of Panx1 or inhibition of direct escape from 
ER-Golgi compartment to lysosomes. This hypothesis is somewhat supported by 
studies showing targeting of mutated prion proteins from the Golgi apparatus to 
lysosomes [166]. 
In keeping with our current findings, we propose a model where full length 
Panx1, capable of trafficking to the cell surface, is preferentially destined to 
lysosomes, as opposed to proteasomal dependent degradation of truncated 
mutant. This paradigm is shifted, however, when Panx1T307-RFP and Panx1 are 
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co-expressed.  An obvious increase in the high mannose species of Panx1T307-
RFP and Panx1 is noticed upon lysosomal and proteasomal inhibition, 
respectively. It is likely that oligomerization of Panx1 with Panx1T307-RFP drives a 
subpopulation of Panx1T307-RFP to lysosomes and a limited proportion of Panx1 
to proteasomes.  
3.4.3 Pathophysiological Significance   
Adequate cell surface trafficking is imperative for Panx1 to form functional single 
membrane channels [25, 59].  A recent report showed that a single amino acid 
substitution from cysteine to serine at residue 346 on the C-tail alters Panx1 
channel properties, such that it leads to the formation of constitutively leaky 
channels, thereby causing cell death [152]. Additionally, a point mutation in the 
Panx1 C-tail at position 337 perturbs the trafficking and distribution at the cell 
surface [47]. The physiological significance of the C-tail is further demonstrated 
by other channel forming proteins such as Cx43, where 97% of mice harboring a 
truncation of carboxyl-terminal (K258stop) die shortly after birth due to a 
defective epidermal barrier caused by impaired differentiation of keratinocytes 
[167].  With a growing significance of Panx1 in initiation and propagation of 
calcium waves [60], tumor suppression [53], release of interleukin-1β [147], 
keratinocyte differentiation [67], and ischemia induced cell death [78], our study 
provides strong evidence for a critical role for the carboxyl terminal tail in 
regulating Panx1 trafficking, oligomerization and degradation.  
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CHAPTER 4: Panx1 Exhibits Prolonged Turnover Kinetics 
and Internalization Pattern Distinct from the Connexin 
Family of Gap Junction Proteins  
 
4.0 OVERVIEW 
 
This study was designed to uncover the turnover kinetics and mechanism(s) 
responsible for Panx1 endocytosis. In particular, endocytic pathways mediated 
by clathrin-, caveolin- and dynamin were closely examined to determine their 
roles in the internalization of Panx1.  A unique pattern of Panx1 turnover was 
characterized using rapid time-lapse imaging, while the degradation of Panx1 
was explored using pharmacological inhibitors. 
_____________________ 
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4.1 INTRODUCTION 
Pannexins (Panxs) are the recently identified vertebrate homologues of the 
integral membrane invertebrate gap junction proteins, innexins [1, 21]. Although 
no sequence homology exists between pannexins and the vertebrate gap 
junction proteins, connexins (Cxs), pannexins were first proposed to belong to 
the gap junction superfamily of proteins based on their homology to innexins. 
Panx and Cxs exhibit tetraspanning transmembrane domains with intracellular 
amino and carboxy termini and two extracellular loops [108]. While there are 21 
members of the connexin family, the pannexin family is comprised of only three 
members: Panx1, Panx2 and Panx3, which are commonly examined in humans, 
mice and rats [21].  Similar to Cx43, Panx1 is ubiquitously expressed in several 
murine tissues, while Panx2 is expressed predominantly in the central nervous 
system, and Panx3 is localized to the skin and cartilage [21, 25]. 
It has been reported that Panx1 oligomerizes into hexamers that traffic to the 
plasma membrane to form cell surface channels [47]. We and others have 
demonstrated that Panx1 achieves three states of glycosylation: Gly0 (core, 
unglycosylated), Gly1 (high mannose form) and Gly2 (complex form) [25, 47]; 
and assembles as single membrane channels that are mechano-sensitive [25, 
57]. In addition, limited evidence also exists to support the formation of Panx1 
intercellular channels [26, 53, 54].  
Homomeric single-membrane Panx1 channels have a large conductance of 550 
pS [57], which is correlated with ionic dysregulation during ischemic conditions, 
subsequently leading to neuronal necrosis [78]. Furthermore, N-methyl-D-
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aspartate receptor (NMDAR)-induced opening of Panx1 channels has been 
implicated in hippocampal epileptiform seizure-like activity [66]. Other studies 
have associated Panx1 channel activation with apoptosis of Xenopus oocytes by 
forming a pore unit with the death complex of the P2X7 receptor [72]. More 
recently, Panx1 was characterized as a target for caspase 3 and 7 cleavage that 
resulted in a constitutively open channel [79]. In the same study, Panx1 channels 
were further shown to mediate phagocyte recruitment by releasing nucleotide 
signals from apoptotic cells [79].  In light of several physiological roles for Panx1, 
it is critical to determine pathways that may regulate its turnover and degradation.  
In the case of Cx43, a unique turnover mechanism exists where gap junction 
plaques are internalized into one of the two contacting cells as large double 
membrane structures called connexosomes [101]. In addition, several studies 
have identified an association between Cx43 and clathrin-coated pits [102-104], 
where the down regulation of clathrin-adaptor protein complex 2 (AP2) as well as 
dynamin GTPase significantly reduced Cx43 gap junction internalization [102]. 
Cx43 has been shown to interact with caveolin (Cav)-1 [168] and Cav-2 to form 
complexes in membrane rafts at the plasma membrane that further regulate the 
level of gap junctional intercellular communication (GJIC) [154]. While more than 
one pathway exists in mediating Cx43 turnover, it has yet to be investigated 
whether pannexins follow the same routes of internalization.   
We and others have reported that Panx1 exhibits slower turnover rates than 
Cx43 [25, 81]. While Cx43 biosynthesis, cell surface delivery, removal from the 
plasma membrane and degradation is completed with a half-life of only 1-3 hours 
130 
 
[82], use of pharmacological blockers have suggested that Panx1 levels at the 
cell surface remain relatively unchanged over a period of 8 hours [25]. Rapid 
turnover kinetics for Cx43 is of physiological importance for cell and tissue 
homeostasis through the regulation of GJIC. This notion is clearly demonstrated 
by a several fold increase in Cx43 expression in the myometrium prior to the 
labor onset, followed by rapid clearing post labor [169, 170]. Similarly, it is 
hypothesized that Panx1 turnover kinetics may also be critical in governing key 
physiological roles in cells. While Cx43 is targeted for both lysosomal and 
proteasomal degradation [105, 106, 171, 172], one report has suggested that 
Panx1 is destined for  lysosomal degradation [47]. However, it is not currently 
known which glycosylated species of Panx1 undergoes lysosomal-mediated 
degradation. Thus, in the current study, we examine whether dynamin- and/or 
caveolin-dependent pathways are involved in Panx1 internalization, how Panx1 
internalizes as assessed by rapid time-lapse imaging, and which Panx1 species 
are destined for lysosomal degradation.  
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4.2 EXPERIMENTAL PROCEDURES 
4.2.1 Cell culture and reagents 
BICR-M1Rk cells, originally derived from rat mammary tumors, were a gift from 
Dieter Hulser, (Stuttgart, Germany [96]) and engineered to stably over-express 
Panx1, as previously described [25]. Cells were maintained at 37°C in high 
glucose DMEM (Invitrogen, Burlington, ON, Canada), supplemented with 10% 
fetal bovine serum, 100 units/ml penicillin, 100 µg/ml streptomycin, and 2 mM L-
glutamine (all from Invitrogen, Burlington, ON, Canada), and sub-cultured using 
0.25% trypsin/1 mM EDTA solution (Invitrogen). 
4.2.2 Transfections 
GFP-tagged WT and K44A DynII expression constructs were kindly provided by 
Dr. Mark A McNiven, (Mayo Clinic College of Medicine, MN) and used for 
conducting transient transfections of BICR-M1Rk cells expressing Panx1. Cells 
grown in 35 mm dishes overnight to ~50-70% confluency were transfected in 
Opti-MEM1 media containing 1 µg of WT or K44A DynII GTPase cDNA 
constructs with 2 μL Lipofectamine 2000. Opti-MEM1 media was replaced with 
complete media 4 hrs post transfection.  
4.2.3 Immunocytochemistry 
Panx1 expressing BICR-M1Rk cells grown overnight on glass coverslips were 
fixed with either 3.7% formaldehyde or 80% methanol and 20% acetone. 
Formaldehyde fixed cells were permeabilized in 1% blocking solution (Bovine 
Serum Albumin-(BSA; Sigma)) containing 0.1% Triton-X-100. Since antibodies 
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against Panx1, clathrin and Cav-1 were all raised in rabbits, a 488 fluorophore 
conjugated Panx1 antibody was engineered as per manufacturer’s directions 
(Pierce Chemical) for dual labeling of Panx1 with these markers. For 
immunolabeling of Panx1 expressing cells for clathrin or Cav-1, cells were first 
incubated with either a 200 fold dilution of polyclonal anti-clathrin heavy chain 
antibody (Abcam), or a 100 fold dilution of polyclonal anti-Cav-1 antibody (BD 
Biosciences Transduction Laboratories) for 1 hr at room temperature, followed by 
incubation with goat anti-rabbit Alexa Fluor555 (1:500, Invitrogen) for 45 min at 
room temperature. Thereafter, cells were washed with PBS and incubated with 
Panx1_488 antibody for an additional 45 min at room temperature before staining 
nuclei with Hoechst 33342 (Invitrogen). For double labeling of Panx1 expressing 
cells for AP2 or Cav-2: cells were first labeled with affinity-purified polyclonal 
Panx1 antibody at a concentration of 2 μg/mL for 1 hr, followed by incubation 
with goat anti-rabbit Alexa Fluor555 (1:500, Invitrogen) for 45 min at room 
temperature. Next, cells were labeled with either monoclonal anti-AP2 (Sigma) or 
monoclonal anti-Cav-2 (BD Biosciences Transduction Laboratories) at a 100 fold 
dilution followed by incubation with goat anti-mouse Alexa Fluor488 (1:500, 
Invitrogen). DynII was labeled using a 50 fold dilution of anti-DynII antibody 
(Santa Cruz) for 1 hr prior to using Texas Red conjugated donkey anti-goat 
(1:200, Jackson Immuno Research Laboratories) as a secondary antibody. Once 
immunolabeled, cells were mounted on glass slides and imaged using a LSM 
510 META confocal microscope (Zeiss) using a 63x oil lens. 
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4.2.4 Pharmacological inhibitors 
Brefeldin A (BFA), cycloheximide (CHX), dynasore, methyl-β-cyclodextrin (MβC) 
and chloroquine were all purchased from Sigma. Cells were treated for 20-32 hr 
with 5 µg/ml BFA and for 1-24 hr with 10 mM MβC. For cycloheximide treatment, 
20 µg/ml was used to inhibit all protein synthesis, and cells were lysed at 2, 4, 6 
and 8 hours following the exposure. Dynasore treatment was used at a 
concentration of 40 µM, consistent with previous studies [102]. Post treatment, 
cells were fixed for immunocytochemistry and lysed for immunoblotting and co-
immunoprecipitation assays.  
4.2.5 Immunoblotting and co-immunoprecipitation  
Immunoblotting and co-immunoprecipitation assays were performed based on 
our previously described protocol [153]. Briefly, cells were lysed in buffer 
containing 150 mM NaCl, 10 mM Tris-HCl, pH 7.4, 1 mM EDTA, 0.5% NP-40, 
and 1% Triton X-100, supplemented with protease inhibitor cocktail (one tablet 
per 10 mL buffer, Roche) and phosphatase inhibitors (1 mM NaF and 1 mM 
Na3VO4). Protein concentrations were measured using a BCA protein 
determination kit (Pierce), and 20-30 µg of total protein lysate was resolved on a 
10% SDS-PAGE gel.  Protein samples were transferred onto nitrocellulose 
membranes using the iBlot Dry Blotting system (Invitrogen) and blocked with 5% 
Blotto Milk (Santa Cruz Biotechnologies) or 3% BSA (Sigma) for 1 hr prior to 
incubating with anti-Panx1 (0.2 µg/mL), anti-clathrin (1:1000, Abcam), anti-AP2 
(1:500, Sigma), anti-DynII (1:250, Santa Cruz), anti-Cav-1 (1:2000) or anti-Cav-2 
(1:2000 BD Biosciences Transduction Laboratories), and anti-GAPDH (1:5000, 
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Millipore) antibodies. Primary antibody binding was detected using mouse IgG IR 
dye 800 at 1:10,000 dilution (Rockland Immunochemicals) or rabbit IgG Alexa 
680 at 1:10,000 dilution (Invitrogen) and blots were scanned with the Odyssey 
infrared imaging system (Licor).  
For co-immunoprecipitation assays, 800-1000 µg of cell lysates were incubated 
overnight in presence of 10 µg/ml anti-Panx1 antibody at 4°C, and immune 
complexes were pulled down using 30 µl (50% suspension) of protein A-
Sepharose beads. Beads were washed in 1x lysis buffer, boiled for 5 min in 30 µl 
of 2x Laemmli buffer, resolved by SDS-PAGE, and immunoblotted with specific 
antibodies to detect Panx1, clathrin, AP2, Cav-1, Cav-2 and DynII.  Although 
primary antibodies were detected using mouse IgG IR dye 800 at 1:10,000 
(Rockland Immunochemicals) or rabbit IgG Alexa 680 at 1:10,000 (Invitrogen), 
detection of co-immunoprecipitates was achieved using the Clean-Blot IP 
Detection Reagent (horse radish peroxidase; Pierce Chemical) as a secondary 
antibody at a 4000 fold dilution for 45 minutes, in order to minimize the 
appearance of the IgG bands in some instances. 
4.2.6 Transferrin uptake 
Cells expressing WT DynII or K44A mutant grown on glass bottom dishes were 
rinsed and incubated in DMEM media containing 20 mM Hepes and 2 mg/ml 
BSA for 1 hr at 37°C. Cells were incubated for 1 hr in presence of 10 µg/ml of 
dynasore. Media was then replaced with media containing 10 µg/ml of 
transferrin-Alexa 555 (Invitrogen) and cells were incubated for additional 45 min 
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at 4°C to block any uptake. Thereafter, cells were imaged either immediately (to 
capture 0 min of uptake) or post 30-40 min after incubation at 37°C.  
4.2.7 Rapid time-lapse imaging 
BICR-M1Rk cells expressing GFP-tagged Panx1 were sub-cultured on glass 
bottom dishes and treated with 5 µg/ml of BFA in culture media for 20 hr at 37°C.  
Prior to imaging, cells were rinsed and replenished with Opti-MEM1 media 
containing fresh BFA. Rapid time-lapse imaging was performed in a temperature 
and C02 controlled humidity chamber, staged on a Zeiss LSM 510 META 
confocal microscope. A region of interest was selected and vesicles budding 
from the plasma membrane were monitored at 30 s time intervals for a total 
period of 23 min.  
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4.3 RESULTS 
4.3.1 Panx1 exhibits a longer turnover rate than Cx43 
We have previously demonstrated that Cx43-positive BICR-M1Rk cells serve as a 
good cell reference model for examining the turnover mechanisms of Cx43 [109], 
and thus this cell system has been employed in this study to investigate the 
internalization process of Panx1. In order to follow the fate of an existing cell 
surface population of Panx1, we used BFA to block the transport of newly 
synthesized proteins to the plasma membrane. BFA-treated cells over-
expressing Panx1 were fixed at various time points prior to immunolabeling for 
Cx43 and Panx1. In untreated cells, Cx43 was visualized as punctate structures 
at cell-cell appositions with some intracellular distribution, whereas Panx1 was 
localized in a relatively uniform pattern at the cell surface (Figure 4.1A). Within 3 
hrs of BFA exposure, most of the Cx43 puncta were cleared from the cell surface 
and newly synthesized protein was retained in an ER-like pattern. In contrast, 
Panx1 was localized predominantly at the cell surface with minimal distribution in 
the intracellular compartment (Figure 4.1A). At 32 hrs of BFA treatment, some 
clearing of Panx1 from the cell surface was evident with increased accumulation 
in an ER-like pattern (Figure 4.1A).  To further compare the kinetic properties 
between pannexins and connexins, Panx1 and Cx43 expression was examined 
in cells under conditions in which protein synthesis was inhibited by CHX.  
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 Figure 4.1 Turnover kinetics of Cx43 and Panx1 
Panx1 expressing, Cx43-positive BICR-M1Rk cells were treated with BFA for up 
to 32 hr prior to immunolabeling for Cx43 or Panx1 (A, red). Note the loss of 
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Cx43 from the cell surface within 3 hr of BFA treatment while Panx1 was 
observed at the cell surface for over 18 hr. Nuclei were stained with Hoechst.   
Bar=10µm. Cells exposed to CHX for 2, 4, 6 and 8 hr were immunoblotted for 
Panx1 and Cx43 (B). When compared to untreated cells (0 hr), immunoblot 
analysis of Panx1 revealed no difference between the banding profile at 2, 4, 6 
and 8 hr of CHX treatment (B); whereas, the level of Cx43 consistently 
diminished following CHX exposure (B). Upon BFA treatment, Panx1 revealed 
the accumulation of the Gly1 species with a reduction of the Gly2 species, which 
remained the same for up to 5 hr upon BFA washout (B). β-actin and GAPDH 
were used as protein loading controls. 
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In agreement with the BFA results and when compared to untreated cells, 
immunoblot analysis of Panx1 levels revealed no difference between the banding 
profiles at 2, 4, 6 and 8 hrs of CHX treatment (Figure 4.1B), whereas there was 
an overall time-dependent decrease in Cx43 levels following CHX exposure 
(Figure 4.1B). These results clearly suggest Panx1 retention at the cell surface is 
much longer than Cx43.   
The rapid turnover and intracellular accumulation of Cx43 can be reversed within 
1 hr of BFA removal [109].  Based on this information, we investigated if the 
recovery dynamics of Panx1 BFA treatment was the same as Cx43 or different. 
BFA treatment of Panx1 expressing cells for 20 hrs reduced the higher 
glycosylated (Gly2) species, with a subsequent increase in the high mannose 
(Gly1) form of Panx1 (Figure 4.1C). However, 5 hr washout of BFA was 
insufficient to return the ratio of the three Panx1 glycosylated species back to 
normal (Figure 4.1C). Collectively, these results suggest that not only is Panx1 
long lived at the cell surface but trafficking of Panx1 through the secretory 
pathway is relatively slower than that of Cx43.  
4.3.2 Panx1 is co-expressed but does not co-
immunoprecipitate with clathrin or AP2 
Clathrin mediated endocytosis (CME) is a well documented process that is 
initiated by the recruitment of clathrin and adaptor proteins (such as AP2) to the 
plasma membrane before forming a coat around the endocytic vesicles and 
budding off [173]. Internalization of Cx43 has previously been correlated, in part, 
with the CME pathway [102].  In order to investigate if Panx1 is internalized 
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through a clathrin driven pathway, we first immunolabeled Panx1 expressing 
BICR-M1Rk cells with antibodies directed against the clathrin heavy chain and 
Panx1.  Panx1 was distributed at the cell surface in a relatively uniform pattern; 
while, clathrin was assembled in a punctate-like pattern at the cell surface with 
some intracellular distribution (Figure 4.2A). Panx1 co-distributed with clathrin 
(Figure 4.2A) and AP2 (Figure 4.2B) at the cell surface. The plasma membrane 
co-distribution of Panx1 with AP2 was not noticeably altered in the presence or 
absence of BFA (Figure 4.2B and C).  Additionally, immunoprecipitation of Panx1 
from WT and Panx1 over-expressing cells did not pull down either clathrin or 
AP2, which were expressed in total lysates at ~180 kDa and ~105-110 kDa, 
respectively (Figure 4.2D). As expected, Panx1 was immunoprecipitated in cells 
over-expressing Panx1 but not in WT cells (Figure 4.2D). This indicates that 
although Panx1 may co-exist in the same compartment with either clathrin or 
AP2, they do not interact.  
4.3.3 Panx1 co-distributes but does not co-
immunoprecipitate with Cav-1 and Cav-2 
Several channels have been reported to localize to the lipid rafts/ caveolae to 
regulate their functional status [174-176]. Caveolae are specialized invaginated 
domains that are formed by the caveolin family of integral membrane proteins, 
which consists of three members: Cav-1, Cav-2 and Cav-3 [177]. Similar to 
Panx1, Cav-1 is ubiquitously expressed in several tissues, whereas Cav-2 is co-
expressed with Cav-1 in various tissues and Cav-3 is primarily restricted to 
muscle [178].  
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Figure 4.2 Panx1 co-distributes, but does not co-Immunoprecipitate with 
clathrin or AP2 
Panx1 expressing BICR-M1Rk cells were immunolabeled for clathrin heavy chain 
(A) or anti-AP2 (B, C). 488-fluorophore conjugated Panx1 antibody detected 
Panx1 (green) with clathrin (red) at the cell surface (A, merge). Double 
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immunofluorescent-labeling revealed the co-distribution of Panx1 (green) with 
AP2 (red) at the cell surface before and after a 20 hr BFA exposure (C). Nuclei 
were stained with Hoechst.  Bar=10µm. Immunoprecipitates of Panx1 from WT 
and Panx1 expressing cells were immunoblotted for Panx1, clathrin and AP2. 
Panx1 (~43-50kD) was successfully pulled down from Panx1 expressing cells 
(under and below the IgG band); however, clathrin (~192kD) or AP2 (~105-
110kD) did not co-immunoprecipitate with Panx1 (B). IB: immunoblot; IP: 
immunoprecipitation, WT: wild type cells; Panx1: Panx1 expressing cells. 
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In order to determine whether caveolins play a role in Panx1 turnover, we 
investigated the localization profile and interaction status of Panx1 between Cav-
1 and Cav-2. Two different fixative methods, formaldehyde and 
acetone/methanol, were employed to detect the intracellular and cell surface 
populations of Cav-1/Cav-2, respectively [154]. In formaldehyde fixed cells, 
Panx1 co-distributed with Cav1 (Figure 4.3A) and co-localized with Cav-2 (Figure 
4.3C) in the intracellular compartment, presumably the Golgi complex. 
Conversely, fixation with acetone/methanol revealed co-expression of Panx1 with 
Cav-1 (Figure 4.3B) and Cav-2 (Figure 4.3D) mainly at cell-cell appositions. To 
examine the potential interaction of Panx1 with Cav-1 and Cav-2, a co-
immunoprecipitation assay was conducted. Panx1 but not Cav-1 was pulled 
down in the immunoprecipitates of Panx1 (Figure 4.3E). Reciprocally, Cav-1 but 
not Panx1 was detected in the immunoprecipitates of Cav-1 (Figure 4.3F). While 
Panx1 was detected in the immunoprecipitates of Panx1 expressing cells, Cav-2 
remained undetected (Figure 4.3G). Conversely, Cav-2 but not Panx1 was 
expressed in the immunoprecipitates of Cav-2 (Figure 4.3H). As expected, total 
cells lysates revealed Panx1 expression only in over-expressing and not the WT 
cells, whereas Cav-1 (Figure 4.3E and F) and Cav-2 (Figure 4.3G and H) were 
detected in both WT and Panx1 over-expressing cells.  
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Figure 4.3 Subcellular distribution and interaction of Panx1 with Cav-1 and 
Cav-2 
BICR-M1Rk cells endogenously expressing Cav-1 and Cav-2, and stably 
expressing Panx1 were fixed with formaldehyde or acetone/methanol prior to 
immunolabeling. Panx1 (green) was found to co-distribute with intracellular and 
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plasma membrane localized Cav-1 and Cav-2 (red) (A-D).   Immunoprecipitates 
of Panx1 (E and G) from WT and Panx1 expressing cells were immunoblotted for 
Panx1, Cav-1 and Cav-2. Panx1 was detected only in the immunoprecipitates of 
Panx1 (E and G) and not in the Cav-1 (F) or Cav-2 (H) immunoprecipitates. 
Conversely, Cav-1(F) and Cav-2 (H) were found in their respective 
immunoprecipitates and not in the Panx1 immunoprecipitates (E and G). IB: 
immunoblot; IP: immunoprecipitation, WT: wild type cells; Panx1: Panx1 
expressing cells. 
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While caveolins become detergent insoluble upon integrating into membrane 
rafts, these rafts can be disrupted with the cholesterol-depleting agent MβC 
[154]. We exposed Panx1 expressing cells to MβC for various time points to 
disrupt caveolin enriched membrane rafts. No substantial difference in the Panx1 
banding pattern (Figure 4.4A) or localization profile (Figure 4.4B) was detected in 
presence of MβC. Interestingly, the highly phosphorylated species of Cx43, 
typically associated with the cell surface and detergent-insoluble pool [154], 
diminished within 1 hr of MβC treatment (Figure 4.4A). Overall, our results 
indicate that while Panx1 co-distributes in the same intracellular and cell surface 
compartments as Cav-1 and Cav-2, there is no clear evidence of their co-
interaction. Additionally, cholesterol extraction from the plasma membrane does 
not noticeably alter the overall Panx1 expression.  
4.3.4 Panx1 internalization is independent of dynamin 
GTPase 
The dynamin GTPase is a common player in mediating caveolar fission, as well 
as budding the clathrin coated vesicles from the plasma membrane [179]. The 
mammalian dynamin family comprises of three members: dynamin I, II and III, 
where dynamin I is brain-enriched, dynamin II is ubiquitously expressed and 
dynamin III is mainly found in testis but also has some enrichment in brain 
especially in postsynaptic areas [180-183]. It is well accepted that a dominant-
negative GTP hydrolyzing mutant of dynamin (K44A) interferes with the function 
of endogenous dynamin by blocking vesicular internalization prior to pinching off 
cell membrane [184].  Therefore in order to investigate the role of dynamin in 
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Figure 4.4 Characterization of methyl-β-cyclodextrin treatment on Panx1     
expression levels and distribution profile 
Western blots revealed that the expression levels of the Panx1 glycosylation 
species remained unaltered after a 24 hr treatment with MβC (A); while the highly 
phosphorylated form of Cx43 was reduced within 1 hr of MβC exposure (A). The 
cell surface distribution of Panx1 (red) remained relatively uniform during the 24 
hrs of MβC treatment (B). Nuclei were counterstained with Hoechst.  Bar=10µm. 
GAPDH was used as a protein loading control. 
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Panx1 internalization, we transfected previously generated GFP-tagged WT and 
K44A DynII in Panx1 over-expressing cells. As expected, an antibody generated 
against DynII detected both the WT (Figure 4.5A) and K44A DynII mutant (Figure 
4.5B), dispersed intracellularly and at the cell surface. Some evidence of Panx1 
co-localization with the WT (Figure 4.5C) and the K44A (Figure 4.5D) DynII 
mutant at the plasma membrane was noticed in untreated cells. Cells co-
expressing Panx1 and WT DynII revealed consistent co-distribution at the cell 
surface with a slight increase in the intracellular localization of Panx1 (Figure 
4.5E).  Conversely, in the presence of BFA, cells co-expressing Panx1 and the 
K44A DynII mutant revealed less intracellular accumulation of Panx1 when 
compared to cells expressing only Panx1 in the same culture environment 
(Figure 4.5F). It was unclear if the increased intracellular expression of Panx1 in 
the absence of the K44A DynII mutant was due to uninhibited turnover of the cell 
surface population of Panx1 or the BFA-induced ER accumulation of Panx1.  
Therefore, we assessed the effect of the WT and K44A DynII mutant over-
expression, and dynasore (a pharmacological inhibitor of dynamin GTPase) on 
the glycosylation species of Panx1.  It was predicted that if dynamin GTPase 
plays a role in Panx1 internalization, then an increase in the Gly2 expression of 
Panx1 would be seen in the presence of the K44A DynII mutant or dynasore. In 
the untreated group, expression of Panx1 alone or in presence of the WT or 
K44A DynII revealed no significant difference among all the three glycosylated 
species of Panx1 (Figure 4.6A and B). In contrast, BFA treatment significantly 
reduced the Gly2 species with a subsequent increase in the Gly1 species of 
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Figure 4.5 Assessment of Panx1 distribution in the presence of WT and 
K44A mutant DynII 
Cells stably expressing Panx1 were transiently transfected with WT or K44A 
DynII expression constructs. Immunolabeling with anti-DynII antibody (red) 
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detected the GFP-tagged WT (green) and K44A (green) DynII mutant at the cell 
surface and within intracellular compartments (A and B). In untreated cells, WT 
and K44A DynII localized with Panx1 primarily at the cell surface (C and D). BFA 
treatment induced similar intracellular and cell surface distribution of Panx1 in the 
presence of WT (E) or K44A DynII (F). Nuclei were counterstained with Hoechst. 
Bar=10µm. 
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Figure 4.6 Characterization of dynamin GTPase on Panx1 expression, 
interaction and transferrin uptake  
Protein lysates of untreated and BFA treated cells expressing Panx1 alone or in 
combination with WT and K44A DynII, were subjected to immunoblotting using 
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anti-Panx1 and anti-DynII antibodies. A significant reduction of the Panx1 Gly2 
species and accumulation of the Gly1 species was observed when cells were 
exposed to BFA (A and B). The overall Panx1 expression levels remained 
unaltered with the co-expression of WT and K44A DynII (A and B). Transient 
transfection of WT and K44A DynII resulted in their expression at approximately 
equal levels (A). In contrast to the WT DynII, temperature sensitive uptake of 
transferrin-Alexa 555 in live cells was greatly reduced in the presence of K44A 
DynII (C). Immunoprecipitates of Panx1 from WT and Panx1 expressing cells 
were probed with anti-Panx1 and anti-DynII antibodies. Panx1 but not DynII was 
detected in the immunoprecipitates of Panx1 (D). GAPDH was used as a protein 
loading control. For statistical analysis, ratios between glycosylation species of 
Panx1 (Gly0, Gly1, Gly2) and GAPDH loading control were taken and a one-way 
ANOVA was performed followed by Tukey’s post test (where ‘a’ is significantly 
different to ‘b’ and ‘c’). Y-axis reflects arbitrary numbers. Bar=10µm. 
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Panx1 in all groups (Figure 4.6A and B). In comparison to the WT DynII, no 
significant increase in the Gly2 species of Panx1 was observed when co-
expressed with the K44A DynII (Figure 4.6A and B). 
To ensure that cells adequately expressed functional exogenous DynII 
constructs, we assessed the protein levels and transferrin uptake capabilities of 
the WT and K44A DynII. Over-expression of the GFP-tagged WT and K44A 
DynII revealed a band at approximately 125-130 kDa (Figure 4.6A). When 
maintained at 4°C, live cells expressing WT or K44A DynII revealed transferrin 
distribution at cell-cell appositions (Figure 4.6C). Following incubation at 37°C, 
the WT DynII showed a clear accumulation of transferrin in the intracellular 
compartment, while K44A DynII restricted the ability of transferrin uptake (Figure 
4.6C). Given the role of dynamin in vesicular budding [184], it was not surprising 
to find that Panx1 did not interact with DynII (Figure 4.6D). Parallel with the DynII 
K44A study, treatment with dynasore alone did not significantly enhance the 
expression of the Panx1 Gly2 species (Figure 4.7A and B). When treated 
together with BFA, dynasore did not show any additive effect on the BFA-induced 
expression levels of the Panx1 Gly2 and Gly1 species (Figure 4.7A and B).  As 
expected, dynasore treatment limited the transferrin uptake when incubated at 
37°C (Figure 4.7C). Overall, our results indicate that Panx1 internalization is 
unique and independent of the dynamin-mediated pathway.  
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Figure 4.7 Panx1 protein expression levels remains unaltered in the 
presence of dynasore  
Panx1 expressing cells were treated in the presence or absence of dynasore 
together with or without BFA for 20 hrs prior to immunoblotting for Panx1. 
Treatment with BFA alone caused a significant reduction in the Gly2 species of 
Panx1 with a marked accumulation of the Gly1 form; while dynasore treatment 
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alone did not change this protein banding profile (A and B). Together, dynasore 
did not cause any additive effect to the BFA induced reduction and accumulation 
of the Gly2 and Gly1 expression, respectively (A and B).  GAPDH was used as a 
protein loading control.  Exposure to dynasore successfully blocked the uptake of 
transferrin-Alexa 555 in live cells at 37°C (C) indicating its effectiveness at 
inhibiting endocytosis. For statistical analysis, ratios between glycosylation 
species of Panx1 (Gly0, Gly1, Gly2) and GAPDH loading control were taken and 
a one-way ANOVA was performed followed by Tukey’s post test (where ‘a’ is 
significantly different to ‘b’ and ‘c’). Y-axis reflects arbitrary numbers. Bar=10µm. 
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4.3.5 Panx1 follows a unique pattern of internalization  
To examine the internalization of Panx1 in live cells, we exposed Panx1-GFP 
over-expressing BICR-M1Rk cells to BFA for 20 hrs prior to capturing rapid-time 
lapse images.  
BFA treatment revealed three distinct distribution profiles of Panx1: a) 
intracellular accumulation around the perinuclear region, b) some evidence of 
uniform distribution at the cell surface, and c) bright clusters at the plasma 
membrane (Figure 4.8). Over time, bright clusters of Panx1-GFP at the cell 
surface formed peculiar tubular-like extensions that stretched away from the 
plasma membrane toward intracellular compartments (Figure 4.8 arrowhead, see 
Movie 4.1). Additionally, Panx1-GFP containing extensions (570 s, Figure 4.8) 
appeared to collapse back onto the plasma membrane (720 s, Figure 4.8). 
Overall, these tubular-like extensions were very slow in internalizing from the cell 
cell surface ranging from ~ 30-45 mins.  Over 30 tubular-extensions were 
visualized in 12 random cells assessed over three independent BFA exposures 
and image capturing sessions. Our imaging data suggests that Panx1 is removed 
from the cell surface along unique tubular-like extensions.  
4.3.6 Panx1 is destined for the lysosomal mediated 
degradation 
In contrast to untreated cells, long term exposure to the pharmacological 
lysosomal inhibitor, chloroquine, revealed a sustained expression of the cell 
surface associated Gly2 species, with a pronounced accumulation of the Gly1 
form of Panx1 (Figure 4.9).  The subcellular distribution of Panx1 in the presence  
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Figure 4.8 Panx1-GFP internalizes in dynamic tubular-like extensions  
Cells stably expressing Panx1-GFP were treated with BFA for 20 hrs prior to 
performing rapid-time lapse imaging in the presence of BFA. Images were 
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acquired every 30 s for the total time of 23 min, however, only a subset of time 
frames are displayed (see Movie 4.1). Panx1-GFP internalized by clustering at 
the plasma membrane (420 s) followed by a dynamic tubular-like extension 
(arrowhead, 450s) that stretched to bud away from the cell surface towards the 
intracellular compartment (600-930s). Minimal extensions of other nearby cluster 
(unfilled arrow, 570 s) were noticed to collapse back on to the cell surface 
instead of detaching itself (720 s). Bar=10µm. 
Movie 4.1 Panx1-GFP follows a unique pattern of internalization through 
dynamic tubular-like extensions  
Rapid time-lapse images of BFA-treated Panx1-GFP expressing cells were 
captured to assess the mechanisms of Panx1 internalization.  Panx1-GFP was 
localized in a relatively uniform manner with some evidence of bright clustering at 
the cell surface that occurred prior to endocytosis. These clusters first extended 
in a tubular-like morphology away from the cell surface and then detached. The 
movie sequence was captured every 30 s over 46 frames representing a total 
elapsed time of 23 min. The movie was accelerated to play in 10.12 s.   
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of chloroquine paralleled its banding profile, as a sub-population was noticed 
around the perinuclear region (presumably lysosomes [47]), with a clear 
evidence of the cell surface expression (Figure 4.9). As expected, BFA treatment 
reduced the Gly2 species with a subsequent increase in the Gly1 form of Panx1 
(Figure 4.9), which was consistent with the loss of the cell surface distribution 
coinciding with an accumulation in an intracellular compartment (Figure 4.9). 
Inhibition of the lysosomal pathway in the presence of BFA resulted in a slight 
increase in expression of the Panx1 Gly2 species when compared to BFA 
treatment alone (Figure 4.9). This finding suggests that accumulation of the 
existing cell surface pool of Panx1 is a result of blocking its internalization and 
degradation through the lysosomal pathway. 
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Figure 4.9 Panx1 is degraded by lysosomes 
Panx1 expressing cells were exposed to BFA and the lysosomal inhibitor 
(chloroquine) alone or together for 20hr prior to immunoblotting (A) and 
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immunolabeling (B) for Panx1.  Chloroquine treatment caused a sustained 
expression of the Gly2 species of Panx1 with an accumulation of the Gly1 form 
(A) which was marked by a increased intracellular distribution of Panx1(B, red).  
BFA-induced reduction of the Panx1 Gly2 species (A) was correlated by the 
increased loss of the cell surface population of Panx1 with a subsequent 
accumulation in the intracellular compartment (B, red). When treated together, a 
subtle rescue of the Panx1 Gly2 species was observed in the presence of the 
lysosomal inhibitor, chloroquine (A). BFA treatment along with chloroquine also 
resulted in the increased cell surface distribution of Panx1 (B, red).  GAPDH was 
used as a protein loading control. Nuclei were counterstained with Hoechst. 
Bar=10µm.  
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4.4 DISCUSSION 
The focus of this study was to elucidate the turnover kinetics and mechanisms for 
internalization and degradation of Panx1. Our data strongly indicates that Panx1 
has a long life at the cell surface, follows a unique pattern of internalization that is 
independent of endocytic pathways mediated by clathrin, caveolins and dynamin 
GTPase, and undergoes lysosomal-based degradation. 
One of the distinguished characteristics of most connexin family members is that 
their physiological regulation is not only at the level of gating the channels open 
or closed [58] but also at the level of gap junction formation and removal [13]. 
The latter level of regulation is possible because most connexins, including Cx43, 
have an unprecedented short half-life for polytopic plasma membrane proteins. In 
this regard, our studies in which protein synthesis or trafficking were blocked by 
pharmacological agents revealed prolonged localization of Panx1 at the cell 
surface, compared to Cx43 gap junctions. Thus, indicating that Panx1 has a 
much longer half-life than Cx43.   
While the highly phosphorylated P2 form of Cx43 [109] is often identified at the 
plasma membrane, it is predominantly the complex glycosylated Gly2 form of 
Panx1 [47, 59] that is destined for cell surface delivery.  The rapid turnover of 
Cx43 in response to BFA is correlated with the loss of the highly phosphorylated 
(P2) species with an accumulation of the lower species (P0) of Cx43 [109]. In our 
studies, a parallel phenomenon occurred where the high mannose Gly1 species 
of Panx1 increased at the expense of the Gly2 species. Since it was possible to 
rescue the trafficking of intracellular accumulated Cx43 and rebuild the normal 
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gap junction complement upon BFA removal [109],  we wanted to follow the 
glycosylation status of Panx1 upon BFA washout as a measure of its recovery 
from intracellular retention.  Interestingly, at no time following BFA removal did 
Panx1 levels at the cell surface return to normal, suggesting that Panx1 has 
delayed trafficking to the cell surface.  Alternatively, it is possible that the 
prolonged exposure to BFA permanently impairs the reorganization of the Golgi 
apparatus thus limiting the rescue of the Panx1 Gly2 expression. Nonetheless, 
our data strongly supports the conclusion that Panx1 half-life while at the cell 
surface is many hours longer than what is documented for Cx43.  
While the internalization mechanisms of connexins, particularly Cx43, have been 
extensively studied, the endocytic pathways governing Panx1 turnover have not 
yet been identified. Whereas, internalization of Cx43 as double membrane 
structures [101] termed connexosomes [13] has previously been linked to the 
CME pathway, while our study is the first to investigate the role of clathrin in 
Panx1 endocytosis. Our data indicates that although Panx1 co-distributes in the 
same cell surface micro-domain as clathrin, its physical interaction with the 
clathrin heavy chain could not be detected. Consistently, while AP2 co-distributed 
with Panx1 at the cell surface they also failed to interact. These finding are in 
contrast to other channels types such as chloride channels [185] or renal outer 
medullary K+ channels (ROMK) [186], where clathrin-mediated internalization is 
marked by co-localization and  co-interaction with clathrin and AP2. Since our 
study only revealed localization of Panx1 and AP2 in the same compartment 
without direct interaction, it is likely that Panx1 endocytosis is independent of 
164 
 
clathrin and thus distinct from Cx43 and other channel forming proteins. As there 
is growing evidence of clathrin-independent pathways for internalization of 
plasma membrane proteins that rely on caveolae and glycolipid rafts [187], our 
next approach was to identify if Panx1 turnover is mediated by caveolin-driven 
pathway. 
Several channels such as K+ [188], Ca2+ [189] and Cl- [190] are reported to 
localize to glycolipid rafts/caveolae for their regulation by caveolins. Our first 
assessment revealed localization of Panx1 with Cav-1 and Cav-2 at the cell 
surface and within intracellular compartments.  While the plasma membrane 
localization of Panx1 with Cav-1 and Cav-2 suggests the presence of Panx1 in 
the lipid rafts- presumably in preparation for internalization, the formaldehyde-
fixed detection of Panx1 with Cav-1 and Cav-2 in the intracellular compartment 
argues for a distinct role. In the case of Cx43, the intracellular distribution with 
Cav-1 and Cav-2, suggested that caveolins might facilitate the delivery of Cx43 
from the Golgi apparatus to cell surface [154]. It is possible that, like Cx43, 
caveolins might be involved in the secretory pathway of Panx1.  Alternatively, 
intracellular co-distribution of caveolins with Panx1 could also reflect the role of 
caveolins in recycling Panx1 from the cell surface to the perinuclear region. This 
notion is in keeping with the previously reported caveolin-mediated internalization 
of the seven transmembrane receptor protein: autocrine motility factor from the 
plasma membrane and its targeting to the ER compartment [191, 192].  
Interestingly, Cav-1 has been identified as a negative regulator of the endocytic 
pathway to the ER compartment, thus providing a more stabilizing role of 
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caveolae at the plasma membrane [187]. The reduced intracellular localization of 
Panx1 with Cav-1 (in comparison to Cav-2) could support the role of Cav-1 in 
maintaining Panx1 at the cell surface instead of its internalization-an argument 
that clearly needs further investigation. Our study has shown that distinct from 
Cx43, Panx1 does not interact with Cav-1 or Cav-2 [154]. Furthermore, the 
cholesterol depleting agent, MβC, known to disrupt the integrity of membrane 
rafts [193] and association of Cx43 with Cav-1/Cav-2 [154], did not noticeably 
alter the Panx1 expression or its cell surface localization. Taken together, our 
results suggest that turnover of Panx1 is independent of caveolin driven pathway.  
As large dynamin GTPase (~100 kDa) has implications in clathrin-dependent 
internalization [194], and caveolar driven fission of the plasma membrane [195], 
we investigated if this molecular player could contribute in Panx1 endocytosis.  
To identify the role of dynamin GTPase in Panx1 internalization, we utilized the 
GTP binding and hydrolyzing mutant, K44A DynII, in the presence or absence of 
BFA. Although Panx1 co-distributed with K44A DynII at the cell surface, blocking 
of the ER-Golgi transport with BFA did not reveal a substantial accumulation of 
Panx1 at the cell surface. It was also interesting to observe that while K44A DynII 
and dynasore blocked the expected transferrin uptake, it did not significantly 
increase the expression of the cell surface species of Panx1. This finding differs 
from the previously documented accumulation of Cx43 plaques [102], and 
enhancement of ROMK (renal outer medullary potassium) channel currents in 
response to K44A DynII over-expression [186]. Thus, our data suggests that 
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Panx1 is internalized in a unique manner that is independent of dynamin 
GTPase.  
Our rapid time-lapse imaging of Panx1-GFP following a long term exposure to 
BFA suggested that clustering of Panx1 at the cell surface is a pre-requisite for 
its turnover. Within several minutes, dynamic tubular-like extensions carrying 
Panx1 pinched off. This pattern of Panx1 internalization was quite distinct from 
the rapid internalization of the double membrane structure of Cx43 that bud from 
preexisting gap junction plaques, and enter one of the two neighboring cells 
[101]. The tubular morphology of Panx1 extensions is quite intriguing and hints to 
the possibility of its internalization via pathways independent of clathrin, caveolin 
and dynamin GTPase. Glycosyl-phosphatidyl-inositol anchored proteins enriched 
early endosomal compartments (GEECs) is one such example that results from 
fusion of uncoated tubulovesicular clathrin-independent carriers (CLICs) directly 
stemming from the plasma membrane [196]. Another feature of the 
CLICs/GEECs endocytic pathway is its independence from dynamin [197] and 
dependence on actin polymerization machinery that is regulated by the Rho 
family GTPase, Cdc42 [198]. As one of the documented binding partners of 
Panx1 [153], it is possible that actin might regulate the endocytic process of 
Panx1. One of the proposed models for actin-dependent endocytosis is the 
elongation of plasma membrane invaginates into a tubular structure through 
active polymerization, followed by scission via myosin motor proteins [199, 200]. 
Such association of actin and myosin II has been reported for endocytosis of 
Cx43 double membrane structures (e.g. connexosomes) [201], and needs to be 
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further investigated in the case of Panx1. Another candidate that has been linked 
to actin remodeling is endosomal-associated GTPase, ADP, ribosylation factor 6 
(Arf6) [202, 203]. The Arf6-mediated pathway is not only independent of dynamin 
and clathrin [204] but is also implicated in the endocytosis and recycling of  K+ 
channels [205].  Interestingly, the Arf6 dependent pathway also includes the 
formation of tube-like structures that are eventually used for recycling the cargo 
back to the plasma membrane [206].  Although the Arf6 pathway needs further 
investigation, it is tempting to speculate that the observed collapse of Panx1-GFP 
tubules back onto the plasma membrane might take advantage of this 
mechanism.  
Once internalized, degradation of Cx43 is linked to both lysosomal [106] and 
proteasomal pathways [171], while consistent with the previous report, our 
current study suggests a role of lysosomes in Panx1 degradation [47]. In our 
studies, while BFA blocked the cell surface trafficking of Panx1, consistent with 
increased Gly1 levels, it did not interrupt Panx1 turnover from the cell surface, as 
revealed by the loss of the Gly2 species.  Surprisingly, chloroquine induced a 
robust increase in the Panx1 Gly1 species, which correlated with Panx1 
localizing to the perinuclear region.  It is possible that long term blockage of 
lysosomal function initiated a negative-feedback mechanism causing Panx1 to 
bypass normal targeting to the cell surface trafficking and direct trafficking to 
lysosomes. Collectively, the sustained expression of the Gly2 species in the 
presence of chloroquine, together with a subtle rescue of the BFA-induced loss 
168 
 
of the Gly2 species, supports that Panx1 typically cycles through the plasma 
membrane en route to lysosomes for final degradation.  
In summary, since Panx1 forms large pore channels implicated in: neuronal 
necrosis [78], epileptic seizure-like activity [66] and initiation of the death complex 
with the P2X7 receptor [72], our study was designed to characterize mechanisms 
related to Panx1 turnover and degradation as potential regulatory mechanisms of 
overall Panx1 function. Our study is the first to show that the turnover of Panx1 is 
slow and is mediated via unique tubular-like extensions.  
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5.1 DISCUSSIONS and CONCLUSIONS 
Objective 1: To characterize the subcellular distribution of Panx1 and Panx3, to 
identify the secretory pathway involved in Panx1 and Panx3 cell surface 
trafficking, to analyze the mobility dynamics of GFP-tagged Panx1 and Panx3 at 
the cell surface and to assess the role of the cytoskeleton in Panx1 trafficking 
and cell surface dynamics. 
Our study was the first to reveal that ectopically expressed Panx1 and Panx3 
trafficked to the cell surface via the ER-Golgi in a Sar1-mediated COPII-
dependent manner [153]. Once at the plasma membrane both pannexin 
members predominantly localized in a relatively uniform manner, as well as in 
dynamic cell surface protrusions [153]. Distinct from Cx43 [96], Panx1 and Panx3 
were highly mobile at all plasma membrane domains [153]. In addition, Panx1 
and Panx3 revealed no interdependency on microtubules for their cell surface 
delivery or mobility [153], as reported for Cx43 [88]. Interestingly, intact 
microfilaments facilitated the free movement of Panx1 carrying vesicles and 
provided overall stability at the cell surface [153].  This study also identified actin 
as a novel direct binding partner of Panx1 at the carboxyl terminal tail [153].  
Objective 2: To identify the role of the carboxyl terminal tail in Panx1 trafficking 
and homomeric interactions. 
To investigate the role of the carboxyl terminal tail (C-tail) of Panx1 in trafficking 
and homomeric interactions, we truncated the polypeptide at residue 307 
(Panx1T307) and ectopically expressed the mutant in BICR-M1Rk and HEK-293T, 
cells devoid of Panx1. Truncation of the Panx1 C-tail dysregulated its cell surface 
delivery resulting in the mutant being retained predominantly in the ER. 
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Furthermore, enzyme-based de-glycosylation experiments revealed that the 
Panx1T307 mutant was glycosylated, albeit, to only the high mannose species. 
Interestingly, co-expression of Panx1 could not rescue the delivery of the 
Panx1T307 mutant to the cell surface and these species had limited co-interaction.  
Thus, these results suggest that the Panx1 C-tail plays a role in oligomerization. 
While our study fully supports the previously reported lysosomal-mediated 
degradation of full length Panx1 [47], our data also supports proteasomal-based 
degradation of mutant Panx1.  
Objective 3: To explore the pathways for Panx1 internalization and degradation. 
Using the pharmacological inhibitors of protein synthesis (cycloheximide) and 
protein trafficking (BFA), we discovered that Panx1 had a much longer predicted 
half-life compared to Cx43 [25]. To uncover the mechanism(s) responsible for 
Panx1 internalization, this study focused on determining the putative involvement 
of clathrin-, caveolin- and dynamin- mediated pathways. Although co-distribution 
of Panx1 with clathrin and adapter protein (AP2) was observed at the cell 
surface, no interaction was detected. This suggested that clathrin-mediated 
internalization may not play a role in Panx1 internalization. Similarly, Panx1 also 
co-distributed with caveolin (Cav)-1 and Cav-2 at the cell surface as well as 
within intracellular compartments. However, co-immunoprecipitation assays 
together with methyl-β cyclodextrin-induced disruption of membrane rafts 
supported the position that Panx1 internalization was independent of caveolins. 
Inhibition of dynamin (DynII) GTPase (characterized in budding off membrane-
bound vesicles) by a dominant-negative GTP hydrolyzing mutant, K44A DynII 
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and the pharmacological inhibitor, dynasore, further revealed that Panx1 turnover 
was independent of dynamin. Interestingly, rapid time lapse imaging revealed a 
novel internalization pattern of Panx1 along dynamic tubular extensions. 
Although Panx1 degradation through the lysosomal pathway was previously 
reported [47], we found that the high mannose species of Panx1 is accumulated 
in the presence of the chloroquine-mediated inhibition of lysosomes.  This finding 
was also correlated with increased perinuclear Panx1 distribution and sustained 
cell surface localization of Panx1.  While Cx43 gets degraded through both 
lysosomal and proteasomal pathways [105], our study strongly supports the 
premise of Panx1 degradation through lysosomes.   
5.2 CONTRIBUTIONS of the RESEARCH 
Prior to this study, the dynamics, regulatory binding partners, pathways and 
compartments involved during the life-cycle of pannexins were essential 
unknown. The overall goal of this study was to investigate if pannexins share 
similar properties to Cx43 gap junctions based on their trafficking, mobility, 
turnover and degradation characteristics. These studies were the first in the field 
to combine GFP tagging and rapid time-lapse imaging to closely monitor and 
address the dynamic properties of pannexins in live mammalian cells. In these 
studies we showed that except for sharing a common secretory pathway, Panx1 
and Panx3 are quite distinct from Cx43. Basically, Panx1 and/or Panx3 exhibited 
a:  a) relatively uniform cell surface distribution, b) extensive and rapid mobility at 
the cell surface, c) prolonged turnover kinetics, and d) unique internalization 
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properties within dynamic tubular extensions that were independent of pathways 
mediated by clathrin, AP-2, Cav-1, Cav-2 and DynII.   
5.2.1 Compared to Cx43, Panx1 and Panx3 exhibit 
distinct subcellular distribution properties, cell surface 
dynamics and cytoskeletal dependency  
 While an uniform cell surface distribution of Panx1 and Panx3 is the 
predominant phenotype observed when these pannexins are expressed in 
reference cell models, additional studies have highlighted other subcellular 
distribution profiles that include diffused localization throughout the cell body and  
punctate cell surface localization [36, 59, 125, 153]. Endogenously expressed 
Panx1 revealed three distinct profiles: a) the relatively uniform cell surface 
pattern at the cell surface of melanoma cells (B16-BL6) [153], and Madin-Darby 
canine kidney cells [47], b) a cell surface punctate pattern as observed in: human 
facial epidermis [25] and Hensen, Claudius and Boettcher cells of the rat cochlea 
[36], and c) diffused cell body localization as seen in an mouse osteoblast cell 
line (MC3T3-E1) [125], spiral limbus and spiral prominence in the rat cochlear 
lateral wall [36], and murine spleen [25]. Whereas endogenous expression of 
Panx3 was found to be within intracellular compartments in rat cochlear bone 
[36], mixed patterns of localization were found both at the  cell surface and 
cytoplasmic localization in murine chondrocytes and chondrogenic cell lines 
(ATDC5) [37]. The differential distribution profiles of Panx1 and Panx3 suggest 
that they may have distinct cellular roles. While the uniform cell surface 
distribution of Panx1 supports the function of cellular communication with the 
extracellular environment -through formation of non-junctional membrane 
175 
 
channels [25, 55], the intracellular localization of pannexins suggests that they 
serve alternate roles. In the study conducted by Vanden Abeele et. al., [54], 
intracellular localized Panx1 was proposed to regulate ER-based calcium 
homeostasis. However, later we showed that Panx1 dysregulated keratinocyte 
differentiation while Panx3 maintained the epidermal integrity of murine skin [67]. 
In addition, our current study revealed a unique enrichment of Panx1 and Panx3 
in dynamic cell surface protrusions, at areas that are devoid of contacting cells 
[153].  While similar distribution of Panx3 in cellular extensions supported its role 
in ATP release and chondrogenic differentiation [37], this phenomenon was not 
typically observed for Cx43, unless non-functional Cx43 mutant was ectopically 
expressed [96].  Collectively, these results support our hypothesis that the 
pannexin family of proteins exhibits a more diverse subcellular localization than 
connexins, broadening their potential cellular roles.   
The cell surface clustering of Cx43 and the relatively uniform distribution of 
Panx1 and Panx3 [153] also supports that these families of proteins acquire 
different states of assembly.  In fact, the rapid lateral movement of Panx1 and 
Panx3 in all plasma membrane microdomains [153], suggests that pannexins are 
likely not packaged into dense crystalline-like structures, as reported for Cx43 
[39]. Pannexin channel packing and cell-cell interactions may be inhibited by 
steric hindrance provided by the bulky carbohydrate moieties at the extracellular 
domain, prohibiting the close proximity of the two adjacent cells.  Electron 
micrographs of Panx1 at the cell surface depicting 20-50 nm of intercellular 
spacing, as opposed to 2-4 nm for Cx43 [47], further supports this notion. The 
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greater mobile fraction of Panx1 and Panx3 in comparison to Cx43 [153], could 
also suggest less interactions with scaffolding proteins and  cytoskeletal 
elements. 
 In our study, nocodazole-induced disruption of microtubules did not significantly 
alter the cell surface distribution of Panx1 and Panx3 [153]. However, this finding 
was quite distinct from Cx43, where the regeneration of gap junction plaques and 
cell surface mobility was minimal upon nocodazole exposure [88, 89], suggesting 
that the delivery of Cx43 was much more dependent on microtubules, as 
compared to Panx1 and Panx3. On the other hand, disruption of microfilaments 
revealed concomitant intracellular accumulation of Panx1 and Panx3 leaving only 
a subpopulation at the cell surface. In contrast, Cx43 gap junctions remain 
relatively more independent to the assembly states of microfilaments [141], 
thereby suggesting that the connexin and pannexin family of proteins have 
distinct dependency on cytoskeletal elements for their cell surface transport, 
mobility and stability.  
5.2.2 The carboxyl terminal tail of Panx1 facilitates its 
trafficking and homomeric interaction 
Several studies have identified the effect of single amino acid substitutions within 
specific motifs of Panx1 [25, 47, 63, 151, 152], however, deletion of an entire 
Panx1 domain has never been investigated. We were particularly keen on 
identifying the role of the C-tail, as this cytoplasmic exposed domain was 
considered a prime candidate for interaction with other regulatory proteins. In 
fact, our work identified that Panx1 C-tail serves as a substrate for direct binding 
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with actin that may provide multifaceted functions in Panx 1 transport, cell 
surface mobility and stability [153].  
Using a truncated mutant of Panx1 lacking the last 119 amino acids from the C-
tail, our study suggested that the C-tail was important in trafficking, homomeric 
interactions and targeted degradation through lysosomes. First, we identified that 
in the absence of the C-tail, Panx1 mutant failed to traffic to the cell surface. 
Second, the Panx1 C-tail truncated mutant was retained primarily within the ER 
where it was found as a core (Gly0) or high-mannose (Gly 1) species. Third, the 
Panx1 C-tail mutant failed to substantially interact with the full length Panx1, 
suggesting a role of the C-tail in homomeric oligomerization. Finally, the ER-
retained truncated mutant was directed to proteasomes for degradation, thus 
supporting the involvement of the endoplasmic reticulum associated degradation 
(ERAD) pathway. Since ERAD is associated with premature degradation of 
misfolded proteins [159, 165], we speculate that the C-terminus may also play an 
important role in the proper folding of Panx1.  
5.2.3 Distinct from Cx43, Panx1 exhibits a longer half-
life and internalizes via unique tubular-like extensions  
In these studies, we showed that the internalization of the cell surface pool of 
Panx1 exceeds the 1.5-3 hrs of Cx43 turnover [25] with an estimated half-life in 
excess of 10 hours. While removal of Cx43 from the cell surface involved 
internalization of the entire or fragments of gap junctions as connexosomes [13] 
into one of the two contacting cells [101], the removal of Panx1 form the cell 
surface appeared to follow tubular extensions. Mechanistically, rapid Cx43 
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internalization was aided by several molecular players such as: dynamin, 
clathrin, AP-2, actin and myosin [102, 104, 201]. However, the internalization of 
Panx1 as noted in our study was independent of clathrin, AP-2, dynamin and 
caveolin-driven pathways. Given the direct association of the Panx1 C-tail with 
microfilaments, it is possible that the internalization of Panx1 might be actin-
mediated. Our studies also supported the lysosomal degradation of internalized 
Panx1. Since Panx1 channel function is linked to neuronal necrosis, epileptic 
seizures-like activity and activation of death complex of P2X7 receptor [66, 72, 
78], our study provides a means of regulating the channel function by processes 
of internalization and degradation.  
5.3 LIMITATIONS and FUTURE DIRECTIONS 
5.3.1 Limitations 
In order to identify the dynamic properties of pannexins in live cells, we tagged 
Panx1 and Panx3 with GFP. Although, Panx1-GFP revealed trafficking and 
localization pattern similar to its wild-type (WT) counterpart, the GFP tagging of 
Panx3 caused a severe trafficking defect [25] with only a trace amount available 
at the cell surface. This posed a limitation in collecting quantifiable data for 
Panx3 mobility at distinct microdomains of plasma membrane. To overcome this 
setback, we co-transfected the untagged Panx3, as it facilitated the adequate 
delivery of Panx3-GFP to the cell surface for assessment of the mobile fraction.  
The comparable percentage (40-50%) of mobile fractions of Panx3-GFP (co-
expressed with Panx3) and Panx1-GFP (co-expressed with Panx1) further 
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suggested that co-expression with the WT counterpart does not hinder the 
mobility of pannexin family members at the plasma membrane.  
In addition, while tagging of Panx1 C-tail truncated mutant with RFP identified its 
role in trafficking, we were unable to parallel our findings using the untagged 
counterpart due to the lack of a quality antibody. It was expected that our 
previously generated antibodies against Panx1 extracellular domain [59], would 
serve as a tool to detect the C-tail truncated mutant of Panx1; however, our 
antibody detection was deemed to be inadequate. Therefore, to control for any 
possible adverse effects of the RFP tag, we also tagged the full length Panx1 
with RFP to be used in comparative studies. Since RFP tagging of full length 
Panx1 exhibited similar distribution characteristics as the untagged counterpart, it 
was employed as a control to study the biological properties of the Panx1 C-tail.  
5.3.2 Future Directions 
Based on our studies, it is clear that pannexins are a distinct family of proteins, 
as compared to connexins.  Part of this distinction may arise from differential 
regulation, based on protein-protein interactions.  While Panx1 was identified to 
directly interact with actin, it remains to be investigated which motif within the 
Panx1 C-tail binds to actin. Consistent with other reports [207, 208], one possible 
approach for identifying the actin binding site within Panx1 is by using serial 
truncations of the C-tail. In addition, it would be interesting to determine if Panx3 
also interacts with actin, as its cell surface localization is also perturbed in 
response to disrupted microfilaments [153]. Although our studies identified a role 
of microfilaments and microtubules in the plasma membrane distribution of 
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Panx3, it has yet to be examined if these cytoskeletal elements play a role in the 
cell surface mobility of Panx3.  
It has been postulated that the overall cellular function of pannexins can be 
regulated, in part, by appropriate trafficking and turnover to/from the plasma 
membrane. While deletion of almost the entire Panx1 C-tail provided evidence for 
its role in the cell surface trafficking, future research should focus on determine if 
there are any targeting motifs within the C-tail that regulate Panx1 trafficking. In 
addition, investigating the role of the C-tail should also be extended to Panx3.   
Our studies also suggest that Panx1 is a long-lived protein; however, it remains 
to be determined if Panx3 also exhibits a prolonged half-life. While Panx1 
internalization was associated with unique tubular-like extensions budding away 
from plasma membrane, the underlying mechanism remains unclear. Since the 
endocytosis of Panx1 was found to be independent of clathrin, AP-2, dynamin 
and caveolin-driven pathways, we speculate that the Panx1 binding protein, actin 
might play a role in its internalization. One of the proposed models of actin-
mediated internalization is the elongation of plasma membrane invaginates into a 
tubular structure through active polymerization, followed by scission via myosin 
motor proteins [199, 200]. Since such association of actin and myosin II has also 
been reported for endocytosis of Cx43 as connexosomes [201], future studies 
should pursue this hypothesis to investigate how Panx1 is internalized via tubular 
extensions.  
In summary, our studies support the hypothesis that in comparison to Cx43, 
Panx1 and Panx3 exhibit distinct subcellular distributions, cell surface mobilities, 
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and cytoskeletal dependencies, while Panx1 possesses unique turnover 
dynamics, and mechanistic pathways leading to its internalization and 
degradation. 
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